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INTRODUCTION 
Biologically important compounds such as interphenylene 
prostaglandin analogs, indoles, quinolines, isoquinolines and 
carbocycles have been synthesized using a catalytic palladium 
approach. Our methodology to the prostaglandin analogs 
involves a novel one pot addition of the two side chains to a 
symmetrical bridged, bicyclic olefin, such as norbornene, in 
the presence of catalytic amounts of a palladium(O) complex. 
The strategy to the synthesis of heterocycles and carbocycles 
involves the intramolecular addition of arylpalladium 
compounds to olefinic bonds in the presence of a phase 
transfer reagent. This methodology offers high yields of 
products and requires mild temperature conditions. 
2 
PART I. ORGANOPALLADIUM APPROACHES TO INTERPHENYLENE 
PROSTAGLANDIN ENDOPEROXIDE ANALOGS 
3 
HISTORICAL 
The prostaglandins are one of the most important classes 
of natural products. They have been the subject of 
investigation for well over 50 years. Since their independent 
1 2 discovery in the 1930s by Von Euler and Goldblatt, many 
bioloqical properties such as vasodepression and smooth muscle 
contraction have been attributed to these compounds. 
Prostaglandins are 20 carbon hydroxyacids with a wide variety 
of bioloqical functions. Some inhibit blood platelet 
aggregation while some induce blood platelet aggregation. In 
addition, they possess many other biological properties which 
include inhibition of gastric and intestinal secretion and 
stimulation of insulin release. Thus, as viewed from the 
standpoint of biological activity, the pharmacological 
potential of prostaglandins is immense. 
Bioloqical pathway to prostaglandins 
Technical difficulties hampered the progress of 
prostaglandin research for almost 30 years. In 1960, the 
structures of prostaglandin (PGE^) and prostaglandin Fgo 
were determined by Bergstrom and Sjovall.^ At that time, 
interest focused on the biogenesis of prostaglandins. It was 
discovered that these primary prostaglandins originated from 
an unsaturated fatty acid, arachidonic acid. By a series of 
enzyme catalyzed reactions, this acid is converted into the 
4 
primary prostaglandins, prostacyclin and the thromboxanes. 
This is usually termed the arachidonic acid cascade (Scheme 
1). The biogenesis of prostaglandins from arachidonic acid 
was discovered independently by two different groups.*'^ 
By the late 1960s, the total synthesis of prostaglandins 
was already in progress. To date numerous syntheses of these 
once rare compounds have been recorded. This topic has been 
the subject of many books and reviews. Among them, the most 
recent review by Noyori and Suzuki^ describes in great detail 
the many synthetic approaches taken by different chemists. 
It is important to note the significant properties of some 
of the primary prostaglandins and the manner by which they 
differ from the other cascade products. PGE^ and PGEg are 
powerful inhibitors of blood platelet aggregation, whereas 
thromboxane (TXAg) is an aggregator of blood platelets. 
These two substances arise from the same endoperoxide 
precursor PGHgf yet they exhibit biologically opposite 
properties. Thus, attention was diverted from the primary 
prostaglandins to the unstable bicyclic endoperoxide precursor 
PGHg (Fig. 1). 
OH 
1 
Figure 1. PGHg 
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Scheme 1. Arachidonic Acid Cascade 
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It was found that PGHg has a v.ery short half life in 
biological (aqueous) systems and yet possesses many 
fascinating properties. PGHg induces rapid irreversible blood 
platelet aggregation and is 200 times more active than PGEg in 
stimulating contraction of rabbit aorta strip, a standard 
assay of prostaglandin activity. However, the half life of 
this interesting compound, as stated earlier, is only five 
minutes in aqueous systems. Even the primary prostaglandins 
which are important biologically have very short half lives 
under biological conditions. 
Need for novel prostaglandin analogs 
In view of the unstable nature of prostaglandins and their 
bicyclic precursor PGHg, the synthesis of stable analogs of 
both PGHg and the primary prostaglandins possessing similar 
activity became highly desirable. Before discussing the 
strategy behind the synthesis of these analogs, it is 
important to understand how PGHg and the other prostaglandins 
are biochemically degraded into biologically inactive 
compounds. It was found that there are three modes of 
enzymatic attack on PGFga* One mode of attack occurs at the 
13,14 double bond to give the 13,14 dihydro-15-oxo product. 
Also occurring simultaneously is the oxidation of the 
carboxylic acid chain which involves sequential removal of 
to of the carboxylic acid side chain. Finally, the 
7 
oxidation of C-20 to the carboxylic acid side chain takes 
place (Scheme 2).^ 
Scheme 2. Degradation of PGFg^ 
OH 
10 
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inactive product 
The synthetic design of many prostaglandin analogs has 
been based on the knowledge of the metabolic degradation 
described above (Scheme 2). Various modifications have been 
made in the 15-hydroxyl group in efforts to retard dehydro-
genation at carbon-15. Notably effective have been 15-methyl 
or 15,15-difluoro compounds. In order to prevent oxidation at 
the carboxylic acid side chain, various modifications have 
been made. These have involved introduction of alkyl groups 
at various carbons or substitution of a heteroatom for a 
8 
carbon. Also, in the carboxylic acid side chain, substitution 
of a meta-substituted aromatic ring for carbons 4 through 6 
has been effective in blocking oxidation. Blockage of 
oxidation of carbon-20 has been effected by the introduction 
of bulky aromatic groups. 
Synthesis and biological properties of PGH^ analogs 
The synthesis of PGHg endoperoxide analogs has involved 
substitution of the unstable peroxy bridge by more stable two 
atom bridges. Thus prepared are N=N, NH-0, S-S, CH=CH, 
CHg-CHg, CHg-O and CHg-NH bridged bicyclic prostaglandin 
endoperoxide analogs. The strategy and the synthesis of some 
p 
PGHg analogs is discussed by Nicolau. To date many analogs 
have been synthesized. Though it is not possible to record 
every PGHg analog that has been synthesized, the following 
list of analogs will give the reader an idea of the 
interesting structural modifications that have been made on 
the unstable PGHg molecule. 
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The above are examples of PGHg. As can be seen from the 
structures, a variety of skeletons have been employed. In 
addition, variations in the stereochemistry of the 
substituents on the bicyclo[2.2.1]heptane ring have also 
resulted in biologically active compounds. 
While discussion of the synthesis of each of the PGH 
analogs is not possible, most syntheses have followed either 
of the following two routes: (a) Diels-Alder route, in which 
the bicyclic ring is constructed by a [4+2] cyclization 
followed by a series of Michael additions and Wittig 
olefination reactions (Scheme 3); (b) prostaglandin route, in 
which the starting material is a naturally occurring 
prostaglandin. An example of the synthesis of one such analog 
is shown below (Scheme 4). 
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Scheme 3. General Synthesis of a PGHg Analog by the 
Diels-Alder Route 
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The Diels-Alder reaction has the disadvantage of giving 
rise to unwanted exo-endo substituted products. In many cases 
the unwanted products predominate. The prostaglandin route 
requires very expensive starting materials, naturally 
occurring prostaglandins, which by themselves are hard to 
synthesize. Therefore, one can see the major drawbacks 
inherent in both routes. 
The table below (Table 1) lists the biological activities 
of all the PGHg analogs listed above. 
Interphenylene prostaglandin analogs 
Among the many steps taken to prevent rapid degradation of 
the primary prostaglandins, it was found that substitution of 
the carboxylic acid side chain by a meta-substituted phenyl 
group proved quite effective in retaining the stability of the 
molecule under biological conditions. A number of inter­
phenylene prostaglandin analogs have been synthesized and some 
of them have been found to possess substantial biological 
activity. A list of such analogs is seen below. 
The general synthetic approaches to all of these prosta­
cyclin and prostaglandin interphenylene analogs have been 
similar to those used in the synthesis of the prostaglandins. 
Most of these compounds possess important biological 
properties and, in addition, greater stability. The labile 
enol ether portion of the prostacyclin has been replaced by 
rigid aromatic groups. As anticipated, these newly made 
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Table 1. Biological activity of known PGHg analogs 
Compound Activity 
Eight times as active as PGGg in stimulating 
blood platelet aggregation; 6 times as potent 
as PGGg in inducing seratonin release; 6.9 
times as active as PGHg and 1450 times as 
active as PGEg in stimulating contraction of 
rabbit aorta strip. 
Potent inhibitor of PGHg induced blood 
platelet aggregation. Thromboxane 
synthetase inhibitor. 
Potent inhibitor of thromboxane Ag 
synthetase. 
Potent inhibitor of thromboxane Ag 
synthetase. 
Potent broncho constrictor^ Inhibits 
artificially induced blood platelet 
aggregation. 
Potent broncho constrictor. Antagonizes PGE^ 
induced C-AMP formation. 
Twenty-four times as active as PGHg and 5000 
times as active as PGE2 stimulating 
contraction of rabbit aorta strip. Induces 
rapid irreversible blood platelet 
aggregation. 
15 
Table 1. Continued 
Compound Activity 
9 Not reported. 
10 Induces rapid platelet aggregation. 
Functions as an antagonist of thromboxane Ag 
receptors. 
11 Selective and potent thromboxane A^ receptor 
antagonist. Inhibits platelet aggregation 
induced by compound 9^ . 
12 Inhibits arachidonic acid induced blood 
platelet aggregation. 
13 Not reported. 
14 Inhibits arachidonic acid induced blood 
platelet aggregation. Inhibits thromboxane 
Ag synthetase. 
15 Inhibits platelet aggregation. Inhibits 
thromboxane A^ synthetase. 
16 Inhibits platelet aggregation. Inhibits 
thromboxane A^ synthetase. 
17 Not reported. 
18 Not reported. 
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Table 1. Continued 
Compound Activity 
19 Not reported. 
20a Specific inhibitor of PGE^ synthetase. 
20b Inhibits synthesis of PGE^. 
21 Weak inhibitor of ADP-induced platelet 
aggregation and thromboxane synthetase. 
22 Not reported. 
23 Inhibits blood platelet aggregation. 
24 1/40 as active as PGGg in inducing blood 
platelet aggregation. Potent veno 
constrictor. 
25 Inhibits blood platelet aggregation. 
26 Not reported. 
27 Not reported. 
28a Mild inhibitor of blood platelet aggregation. 
28b Potent inhibitor of blood platelet 
aggregation. 
17 
HO^C 
29 32) 30 (33) 
31 (33) 32 (33) 
OH 
33 (34, 35) 
40 
(35 
a: 
. 36 
X = 
and 
OH 
38) 
b: X = CH3 
C:  X = NH2 
d: X = 
0 
e: X = 
-
0 
34 (34, 35, 36, 37) 
a: X = OH 
B: X = NH^ 
a: -COgH 
HO 
OH 
36 (39) 
Figure 2. Interphenylene prostaglandin analogs 
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Figure 2. Continued 
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Figure 2. Continued 
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analogs possess biological properties similar to PGIg. The 
newly introduced aromatic groups offer stability to these 
molecules in biological systems. Table 2 below lists the 
biological properties of these interphenylene prostaglandin 
analogs. 
The biological properties of both PGHg and interphenylene 
prostaglandin analogs stimulated our own interest in that 
area. It was conceived that "interphenylene PGH analogs" 
would not only be an interesting addition to the list of known 
prostaglandin analogs, but also important biologically. The 
following chapter will discuss in detail the compounds 
envisioned for our synthetic and biological study. 
As stated earlier in this chapter, present approaches to 
the synthesis of PGHg analogs have certain disadvantages. In 
order to circumvent the problems pertaining to stereochemis­
try, Larock and co-workers have used novel organometallic 
approaches to develop rapid, stereospecific routes to some of 
the PGHg analogs seen above. The objective of this research 
has been to apply various aspects of organometallic chemistry 
towards the synthesis of interphenylene prostaglandin analogs. 
It was envisioned that an organopalladium species would 
stereospecifically add to strained bicyclic olefins such as 
norbornene, norbornadiene and 7-oxanorbornene, to yield 
intermediate p-alkyl palladium compounds which would then be 
trapped by a terminal alkyne. This would result in the 
22 
Table 2. Biological properties of interphenylene 
prostaglandin analogs 
Compound Activity 
29 Not reported. 
30 Potent inhibitor of blood platelet 
aggregation. 
31 Potent inhibitor of blood platelet 
aggregation. 
32 No PGIg activity. 
33 Potent inhibitor of ADP-induced blood 
platelet aggregation. 
34a Thirty times more potent than PGE^ as an 
inhibitor of ADP-induced human platelet 
aggregation. 
34b Not reported. 
35a Potent inhibitor of ADP-induced human 
platelet aggregation. 
35b Potent inhibitor of human platelet 
aggregation. 
35c Not reported. 
35d Not reported. 
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Table 2. Continued 
Compound Activity 
35e Not reported. 
36 Potent inhibitor of human blood platelet 
aggregation and dilator of perfused cat 
artery. 
37 Showed more potency than PGE^, but less than 
PGIgf in inhibiting platelet aggregation and 
dilating isolated perfused cat coronary 
artery. 
38 Not reported. 
39 Potent inhibitor of blood platelet 
aggregation. 
40a Not reported. 
40b Not reported. 
41 Not reported. 
42 Not reported. 
43 Almost twice as potent as PGE^ in platelet 
aggregation. 
44 Not reported. 
24 
Table 2. Continued 
Compound Activity 
45 Not reported. 
46a As active as PGIg (PGIg mimic) in inhibiting 
platelet aggregation and lowering blood 
pressure. 
46b As active as PGIg (PGIg mimic) in inhibiting 
platelet aggregation and lowering blood 
pressure. 
47a Not reported. 
47b Not reported. 
48 Not reported. 
49a Potent as PGIg, but possesses considerably 
enhanced stability towards chemical and 
metabolic degradation. 
49b Potent as PGIg, but possesses considerably 
enhanced stability towards chemical and 
metabolic degradation. 
50a Not reported. 
50b Not reported. 
25 
Table 2. Continued 
Compound Activity 
51 Potent inhibitor of blood platelet 
aggregation. 
52 Inhibits exvivo platelet aggregation. Also 
has gastric antisecretory and antiulcer 
activities. 
53 Useful as cardiovascular agents, platelet 
aggregation inhibitors, antithrombotions and 
bronchodilators (no data) . 
54 Not reported. 
55 Not reported. 
addition of the two carbon chains to a symmetric double bond 
in one step, stereospecifically. Also, this would be the 
shortest route to interphenylene prostaglandin analogs. 
Hopefully, the compounds obtained would not only possess 
structural diversity, but also important biological activity. 
The next chapter will discuss, in detail, the synthetic 
strategy and the experimental results of our research. 
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ORGANOPALLADIUM APPROACHES TO INTERPHENYLENE 
PROSTAGLANDIN ENDOPEROXIDE ANALOGS 
Historical 
As noted in the previous chapter, some of the 
interphenylene analogs of the primary prostaglandins not only 
possess structural simplicity, but also potent biological 
activity. These observations stimulated our interest in the 
synthesis of novel interphenylene prostaglandin endoperoxide 
analogs. 
Earlier work by Larock and co-workers on the synthesis of 
prostaglandin endoperoxides has involved organopalladium 
additions to bicyclic olefins with subsequent acetylide 
displacement (eg. 1).^^ Using this approach, a number of 
prostaglandin endoperoxide (PGHg) analogs have been 
synthesized. Most of these are quite active in the inhibition 
of blood platelet aggregation, but are not as potent as 
previously synthesized analogs and several natural 
prostaglandins. The general scheme for the synthesis of one 
such analog is shown below (Scheme 5). 
R 
( 1 )  
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Scheme 5 
L.O  ^ClHg-^  ^
i I PdCl/2 
OR 56 
2 PPh, 
•3 
NaOH 
MeOH 
OH OR 
58 57 
Organomercurials are relatively inert compounds. However, 
transmetallation occurs easily with Pd(II) salts, giving rise 
to an intermediate organopalladium species which rapidly 
inserts the olefin to form a a-alkyl palladium complex 56. 
Lack of a cis-B hydrogen prevents this palladium intermediate 
from undergoing palladium hydride, "HPdX", elimination. 
Further, the sulfur atom can coordinate to the palladium 
stabilizing intermediate Acetylide displacement of the 
palladium moiety in the presence of two equivalents of 
triphenylphosphine then affords intermediate S2_ which can be 
easily converted to analog ^  by known synthetic transforma­
tions. This approach introduces the two side chains in two 
28 
separate steps, circumventing problems that might arise 
employing a Diels-Alder approach. 
Catellani and Chiusoli^^'^^ have developed a novel and 
elegant approach to effect the same transformation (see eq. 
1). This involves the one step addition of a vinyl or 
aromatic group and a terminal acetylene to the strained double 
bond of a bicyclic olefin, such as norbornene. The reaction 
involves treatment of a vinyl or an aryl bromide with a 
terminal acetylene and norbornene in the presence of catalytic 
amounts of tetrakis(triphenylphosphine)palladium(0) 
[PdfPPhg)^] and one equivalent of sodium acetate (eq. 2). 
3% Pd(PPh ) /l^ 
: < I + RBr + R'CeCH ^ I \ JL (2) 
1 ^ 1 NaOAc R = vinyl or aryl R' 
A 
No further efforts were made by Chiusoli to extend this 
synthetic route to prostaglandin endoperoxide analogs. We 
thought that this approach might prove effective for such 
syntheses. The interphenylene prostaglandin analogs shown 
below (Fig. 3) were considered as suitable target molecules. 
If this one pot approach were successful, the two side chains 
would be introduced in just one step. The scheme envisioned 
is shown below (Scheme 6). 
29 
X = 0, CH^ 
59 60 
CCUH ii:cC 
OH 
61 
Figure 3. Interphenylene prostaglandin analogs 
Scheme 6 
D H cat. PdCPPhg)^ kj " «"=-5-=5»11 ' 
OH 
Y = CI, Br, I 
The analogs 60^ and ^  differ from the natural 
prostaglandins and other prostaglandin analogs with respect to 
the stereochemistry of the two side chains (cis, compared to 
the trans stereochemistry found in prostaglandins and most 
30 
other analogs). The presence of an acetylenic, instead of a 
vinyl, moiety was of interest since it has imparted greater 
biological potency in other prostaglandin analogs.Thus, it 
was thought that this modification might introduce greater 
biological activity into our target molecules (Fig. 3). 
Additionally, it was thought that this proposed synthetic 
method when applied to substituted aryl halides, would give 
rise to a new set of analogs shown in Figure 4. In these 
.CO^ H 
OH 
X = 0 (^) , CH^ (63) 
Figure 4. Interphenylene prostaglandin analogs 
analogs it was hoped that the 1,4-substituted phenyl ring 
would mimic the cis double bond found in natural 
prostaglandins, at the same time blocking oxidation during 
biochemical processes. The lower side chain, however, is the 
same as in the benzyl analogs. The current interest in oxygen 
derivatives of encouraged us to examine the synthesis 
and properties of PGH analogs bearing an oxygen in the one 
atom bridge. Hopefully, these compounds (Figs. 3 and 4) would 
possess interesting biological activity. Prior to our work, 
interphenylene PGH analogs of the type indicated in Figs. 3 
and 4 were unknown. 
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•Results and discussion 
As a model study, it was decided to apply Chiusoli's 
ikions^^ to the following reaction (eq. 3). When 
XCHg _ PdtPPhg)^ 
+ HC=CCHC_H.1 
• NaOAc 
OH . ^ 
X = Br, CI anxsole 
A 
(3) 
È1 
norbornene, benzyl bromide and racemic l-octyn-3-ol were 
heated at 80°C in the presence of 3% PdfPPhg)^ in degassed 
anisole, an intractable product mixture was obtained. 
However, when benzyl chloride was subjected to similar 
conditions, excellent yields of the anticipated product 6^ 
were obtained. In order to optimize the yield, we examined 
several different reaction conditions (Table 3). 
In each of these reactions, the concentrations of benzyl 
chloride, racemic l-octyn-3-ol and sodium acetate were kept 
constant (one equivalent with respect to the olefin). 
The exclusive formation of the cis-exo product may be 
explained by the following mechanism (Scheme 7). The first 
step involves the oxidative addition of benzyl chloride to the 
Pd(PPh2)^ catalyst giving rise to the intermediate benzyl-
palladium chloride complex. Rapid insertion of norbornene 
32 
Table 3. Reaction conditions examined in the synthesis of 
compound 65 
Reaction Reaction Isolated 
Equiv. % Pd time temperature yield of 
Entry of olefin catalyst (days) (°C) 65 (%) 
1 2 3 1 65 30 
2 2 3 2 65 35 
3 4 3 1 65 68 
4 4 8 1 70 81 
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Scheme 7 
CHgCl 
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<-
HCHCR 
Pd-Cl 
Pd-C=C-R 
66 
+ 2 L 
V t. \ 
PdL, 
È1 
into the carbon-palladium bond of this complex results in the 
formation of a n-alkyl palladium intermediate 6^. This 
intermediate in turn complexes with the acetylene giving rise 
to a positively charged palladium species. Removal of the 
acetylenic hydrogen by base generates an organopalladium 
intermediate, which upon reductive elimination results in the 
formation of the final adduct. It should he noted that the 
absence of a cis g-hydrogen in the complex 66 prevents "HPdX" 
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elimination. Since benzylpalladium chloride addition to 
norbornene is cis and reductive elimination in the final step 
proceeds with retention of configuration, the product obtained 
is exclusively cis-exo. 
This one pot addition reaction was then extended to 
norbornadiene, bicyclo[2.2.2]octene and 5,6-diaza-5,6-dicarbo-
ethoxynorbornene. The reaction with norbornadiene proceeded 
smoothly although accompanied by formation of a minor impurity 
(~5% by NMR spectral analysis) inseparable by chromato­
graphy. In this case eight eguivalents of diene were used in 
order to prevent diaddition to the diene. The final product 
67 was obtained in 53% yield. Increasing the amount of diene 
.CH-Cl 
+ 1 + HCECCHC^H 
^ iH 
5 11 
67 53% 
8% PdtPPhg)^ 
NaOAc 
anisole 
80°C 
one day (4) 
to 20 eguivalents made no significant change in the yield or 
in the relative amount of impurity formed. In the case of 
bicyclo [2.2.2]octene and 5,6-diaza-5,6-dicarboethoxynor-
bornene, the reaction did not give the desired addition 
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product. Varying the reaction conditions did not change the 
results, as many products were obtained in each case. 
Synthesis of methyl(3-chloromethylphenoxy)acetate 
Having obtained the optimal reaction conditions for the model 
systems, it was decided to prepare the desired ester analogs, 
using optically pure (S)-l-octyn-3-ol and methyl(3-chloro­
methylphenoxy) acetate (6^). The synthesis of compound £8 was 
accomplished in a straightforward manner starting with 
m-hydroxybenzaldehyde (Scheme 8). Treatment of m-hydroxy-
benzaldehyde with methyl bromoacetate in the presence of 
Scheme 8 
HC /CHO 
acetone 
reflux 
overnight 69 
88% distilled 
NaBH^ 
MeOH 
-5°C+0°C 
CH^SOgCl 
CI CO2CH2 Collidine HO 
LiCI/DMF 
68 82% 0°C, 2 hours 70 95% 
potassium carbonate in refluxing acetone for 16 hours gave the 
formyl ester ^  in an 88% distilled yield. Selective 
reduction of the aldehyde in the presence of the ester at 0°C 
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with sodium borohydride gave the alcohol 70_ in 95% yield. 
Conversion of the benzylic alcohol to the chloride via the 
mesylate was achieved in 82% yield using Meyers' procedure. 
Resolution of optically pure (S)-l-octyn-3-ol 
Optically pure (S)-l-octyn-3-ol was resolved using a modifica­
tion of Fried's procedure.The general scheme that was 
adopted for the resolution is shown below (Scheme 9). Racemic 
H 
cc 
(±) HO-C-CHCH > 
165-C 
0 
5^^ 11 21 hours ' "cO_-C-ChCH 
2 
71 
(-) HjNP 
CH3 
- Ç -
H 
•Ph four 
crystallizations 
H 
(-)-HOMI.C-I.'Ç=CH [a]^°CHCl,=-6.79 <-
à 
C, 
72 
10% NaOH, 60"C 
one hour 
ÇH3 
CO'^H^N V- Ç—Ph 
Vll 
CO, 
H j 
C = CH 
C5H11 
l-octyn-3-ol was heated with phthalic anhydride at 160-165°C 
for 21 hours under nitrogen. The half phthalate ester 22. was 
obtained in 55% yield. Recrystallization of the half 
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phthalate ester from benzene (twice) and subsequent treatment 
with (S)-(-)-phenethylamine in refluxing dichloromethane for 
30 minutes yielded the amine salt. The mother liquor was 
cooled to room temperature and then kept in a freezer 
overnight. The S,S diastereomer of the amine salt 
crystallizes out. After four successive recrystallizations 
from dichloromethane, the amine salt was obtained optically 
pure. It should be noted that to affect recrystallization of 
the desired diastereomer of the amine salt (S,S), it was 
critical to recrystallize the half phthalate ester twice 
before treatment with the amine. The optical purity of the 
amine salt was determined by NMR spectral analysis, 
monitoring the ethanol hydrogens of the two diastereomers, 
which appeared as two doublets at 5 2.48 and 6 2.52 (J = 1.5 
Hz). The doublet at ô 2.48 corresponds to the S,S 
diastereomer. Saponification with 10% sodium hydroxide 
yielded the optically pure alcohol 72. in an 88% distilled 
yield. The optical rotation was measured in chloroform; 
[ a ^ J ^ O c H C l g  =  - 6 . 7 9  [ l i t e r a t u r e  v a l u e , C H C l ,  =  - 5 . 5 ] .  
The optical purity of the alcohol itself was established by 
NMR spectral analysis using an optically active shift reagent 
tris-[3-heptafluoropropylhydroxymethylene)-d-camphorato]-
europium(III). The optical purity of the alcohol 72. w&s 
~100%. 
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Interphenylene PGH ester analogs Having obtained the 
requisite starting materials, we decided to synthesize the 
interphenylene PGH ester analogs via the one pot synthetic 
route employed in the model studies. When norbornene (four 
equivalents), optically pure (S)-l-octyn-3-ol (22) and the 
substituted benzyl chloride ^  were heated at "70°C for a day 
in anisole in the presence of 8% PdCPPhj)^ and one equivalent 
of anhydrous sodium acetate, the expected product 13. was 
obtained in 58% isolated yield as an inseparable mixture of 
the two possible diastereomers (eg. 5). 
4 + 
CI 
+ HCEC^-C-^C-H 
OH 
5"ir 
8% PdCPPhj)^ 
> 
NaOAc 
70-72°C 
one day 
anisole 
58% 
H 
H 
OH 73 
The reaction was then extended to norbornadiene (eight 
equivalents of the diene were used), and the desired product 
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74 was obtained as a mixture of diastereomers in 37% isolated 
yield (eq. 6). 
iiD 
O.CH 
OH 
-Ç-
H 
+ HC=C^C-^CgH^^ 
8% PdCPPhj)^ 
NaOAc 
80°C, one day 
anisole 
37% 
OH 
( 6 )  
CO2CH3 
When 7-oxa-norbornene^^ was subjected to similar 
conditions, the expected product 7^ as a mixture of 
diastereomers was obtained in 34% isolated yield along with 
the diadduct 76 (eq. 7). The formation of the diadduct 76 
ci ^COgCH^ OH 
+ HC5C^C4C_H 
8% Pd(PPh^ )^  
NaOAc 
5 11 70°C, one day (^) 
^ anisole 
40 
OH 
76 (14%) 
could be explained by the following scheme (Scheme 10). 
It is envisioned that the initial a-alkyl palladium 
Scheme 10 
Pd-Cl 
I 
L 
R'C=CH 
76 «• 
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intermediate 76A could add to another 7-oxanorbornene molecule 
giving rise to a second o-alkylpalladium species, which then 
reacts with the terminal alkyne to yield compound 76. 
Decreasing the amount of olefin used to two equivalents 
had no effect on the yield of the product or in eliminating 
diadduct formation (compound 7^). Under these conditions, the 
yield of compound 75 dropped to 26%. Raising the temperature 
to 80°C, while maintaining the usual conditions of four 
equivalents of olefin, increased the yield of the desired 
compound 75. 45%. 
The NMR spectral data for compounds 73, and 73 deserve 
special mention. Proton NMR spectral and decoupling studies 
provided proof of the relative stereochemistry of the two side 
chains. For the sake of discussion, compounds 7^ , 74. 2^  
will be numbered in the following manner around the bicyclic 
system (Fig. 5). 
OH 
Figure 5. X = O, CH2 
In the case of compound 73. (X = CHg), the NMR spectrum 
showed the presence of 26 resonances, all occurring in the 
expected absorption region. Since there are only 25 different 
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carbons in compound 7^, the extra peak could arise from the 
diastereomer of compound 73^, wherein one of the carbons 
absorbs in a slightly different region. The NMR spectrum 
thus revealed the existence of the two diastereomers of 
compound 73. 
The NMR spectrum of compound 22 also revealed some 
interesting features. The HC(2) hydrogen exhibits a doublet 
at S 2.62 with J = 8.7 Hz. The coupling constants for cis-
endo hydrogens of similar systems have coupling constants 
varying from 8-10 Hz.^^ Since HC(2) and HC(1) are nearly 
perpendicular to one another, coupling between these two 
hydrogens is greatly reduced. The two diastereotopic benzylic 
hydrogens have different chemical shift values. One hydrogen 
absorbs at 6 2.86 and the other around 5 2.42. At this stage, 
decoupling experiments proved to be very helpful in confirming 
the proton assignment. Irradiation of the resonance at ô 2.86 
caused the peak at 5 2.42 to collapse to a doublet (J = 8.3 
Hz). Thus, the peaks at 6 2.86 and 5 2.42 can be assigned to 
the diastereotopic benzylic hydrogens. Also, during the same 
decoupling experiment the peak due to HC(3) was observed as a 
triplet at 6 1.86 with J = 6 Hz. In conclusion, irradiation 
of one of the benzylic hydrogens resulted in changes in the 
absorption patterns of the other benzylic hydrogen and HC(3). 
No other changes were observed elsewhere in the spectrum. 
Irradiation of the peak at 6 2.42 caused the absorption at 6 
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2.86 to collapse to a singlet and the peak at 6 1.86 to 
collapse to a very broad triplet, but the peak at s 2.35 
remained unchanged. This confirms the previous assignment. 
Irradiation of the peak at 5 1.86 caused the peak at ô 2.62 to 
collapse to a singlet. Thus, the absorption at 6 2.62 can be 
assigned to HC(2), while the peaks at 6 2.86 and 6 2.42 
collapse to doublets with J = 14.0 Hz. The decoupling 
experiments have, therefore, removed any ambiguities that were 
originally present in the proton NMR spectral assignments. 
Exact mass and infrared spectral data offer further evidence 
for the overall structure of the compound as assigned. 
The spectral properties of compound 21 were quite similar 
to that of compound 22.' The NMR spectrum exhibited the 
presence of 25 resonances; exactly the number expected for the 
proposed structure. The presence of the other diastereomer 
was inferred from the absorption of one of the carbons at 
5 38.24. This carbon absorption had a broadened shoulder 
relative to the other carbon absorptions, possibly indicating 
the carbon center belonging to the other diastereomer. The 
NMR spectrum of compound JA. revealed nothing notably different 
from compound 22" The vinyl region appeared as a broad 
singlet. Decoupling experiments similar to those performed on 
compound 22 were useful in assigning HC(2), HC(3) and the 
benzylic hydrogens. Excluding very minor changes in chemical 
shifts, the and NMR spectra of compound 21 were nearly 
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identical to those of compound 7^. Infrared and mass spectral 
data confirmed the structure as assigned. 
The NMR spectrum of compound 75. turned out to be 
interesting as well as straightforward to interpret. The 
hydrogens of the bridgehead carbons, HC(1) and HC(4), have 
considerable differences in their chemical shifts, 6 4.55 and 
6 4.26 respectively. As expected, these turned out to be 
broadened doublets with J = 4.2 Hz and J = 5.6 Hz 
respectively. One of the benzylic hydrogens ( 6 2.83-2.89) was 
buried under the doublet due to HC(2) ( 6 2.86). These 
assignments were confirmed by decoupling studies. The peak 
due to HC(3) appeared as a multiplet in the range of 6 
2.06-2.19. Upon irradiating the hydrogens giving rise to the 
peak at 6 2.86, the multiplet at 6 2.06-2.19 collapsed to a 
doublet with 2 - 9 Hz. Thus, HC(3) couples with only one of 
the benzylic hydrogens now, the coupling with HC(4) being too 
small to observe. Upon irradiation of the peaks at S 2.57 and 
à 2.62, the multiplet centered at 5 2.83-2.89 collapses to a 
less complicated multiplet, reinforcing the belief that the 
vicinal coupling between the two benzylic hydrogens does 
exist. Simultaneously, a change in multiplicity is observed 
in the region 6 2.06-2.19 due to the endo proton on C-3. This 
can only be attributed to the other benzylic hydrogen at S 
2.62. Hence the multiplet in the region 6 2.06-2.19 is 
assigned to HC(3). Irradiation of the peak at S 2.15 causes 
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changes in multiplicity in the region 6 2.57-2.62, further 
confirming this assignment. Infrared and exact mass 
measurements further confirmed the structure of the compound. 
The interpretation of spectra of the diadduct 7_6 was more 
difficult than that of compound 7_5. The NMR spectrum did 
not offer sufficient evidence as to its structure. However, 
the NMR spectrum showed the presence of 31 resonances; 30 
different absorptions are expected for the proposed structure. 
The extra carbon absorption could be attributed to the other 
diastereomer of compound 76_. Evidence from IR studies and 
exact mass measurements, finally confirmed its structure. The 
stereochemistry assigned to this compound is based only on 
mechanistic arguments. 
The esters 73 and 7_4 were then converted to the acids _6£ 
and by saponification with 2N KOH in refluxing methanol. 
Ester 7_5 was converted to the acid 5_9; by stirring with 2N KOH 
at room temperature for two days. The yields of acids ^ 
and 61 were 98%, 95% and 88% respectively (egs. 8 and 9). 
•CO^CHs 
2N KOH ^ 
U MeOH ^ 
two hours 
or 
two days 
room temperature 
( 8 )  
59 X = O 98% 
OH M X = CHJ 95% 
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•CO^H 
2N KOH ^ 
IV MeOH 
two hours (9) 
3 OH 
6 1  88% 
Compounds when tested by E. R. Squibb and 
Sons, Inc. for inhibition of blood platelet aggregation 
induced by arachidonic acid, proved to be virtually inactive. 
Arylpalladation approaches to interphenylene PGH ester 
analogs Replacing the substituted benzyl halide with a 
para substituted bromo- or iodoarene, in theory, should lead 
to esters of the interphenylene analogs shown earlier (see 
Fig. 4). Simple hydrolysis of the resulting esters would then 
yield the corresponding acids. The strategy involved in the 
synthesis of these compounds is straightforward (Scheme 11). 
Synthesis of p-iodo-and p-bromophenoxy-acetic-acid methyl 
esters The requisite esters were made in two steps 
starting from the corresponding halophenols using the general 
procedure shown below (Scheme 12).^^'^® Treatment of the 
2-bromo or p-iodo phenols with chloroacetic acid in the 
presence of two equivalents of sodium hydroxide in refluxing 
water gave the corresponding phenoxyacetic acid derivatives in 
>90% yield. Esterification of the acids with methanol in the 
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Scheme 11 
xV 
X 
HC=CI 
OH 
H 
C5H1I 
= Br, I 
8% PdCPPh^)^ 
NaOAc 
A 
KOH MeOH 
reflux 
Scheme 12 
OH 
X Y \ 
NaOH 
OH + CICH2CO2H 
H^O 
4 hours 
\k 
H2SO4 
4-6 hours 
X -^ -^Os^ cOgCH, 
X = Br, 65% 
X = I, 90% 
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presence of catalytic amounts of concentrated sulfuric acid 
afforded the corresponding esters in high yields. 
Arylpalladation reactions When norbornene, methyl 
£-bromophenoxyacetate and optically pure (S)-l-octyn-3-ol were 
treated with 8% PdfPPhg)^ and anhydrous sodium acetate in 
anisole for two days at 80®C, the expected product 1J_ was 
obtained in a poor yield with a large amount of unreacted 
starting halide. Surprisingly, the alcohol could not be 
recovered (eg. 10). Changing the reaction conditions or 
OH 
+ 
H 
8% PdfPPhg)^ 
NaOAc 
80°C 
2 days 
CO2CH3 
(10) 
Br 
-0  ^
^xCOzCHg 
OH 
77 11% 76! 
switching to the more reactive iodoarene gave no improvement 
in the yield of the product (Table 4). In fact, the 
previously derived optimal conditions for the bromoarene 
failed to yield any of the desired product with the iodoarene 
(entry 1, Table 4). 
It was thought that a protected alcohol might improve the 
reaction in case the alcohol was the source of the problem. 
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Table 4. Reaction conditions for the arylpalladation 
reactions 
p-XCgH^OCHgCOgCHg 
X = 
Reaction 
temperature 
(*C) 
Reaction 
time 
(days) 
Isolated 
yield of 
product 
77 (%) 
Yield of 
recovered 
aryl halide 
(%) 
Br 80 2 11 76 
Br 80 2 - 93 
Br 90 4.5 many 
products 
none 
isolated 
I 80 2 <5 30 
®In each of the reactions, the olefin was taken in a 
fourfold excess with respect to the aryl halide and the 
alcohol. The amount of Pd(PPh_). catalyst remained the same 
( 8 % ) .  •  ^  
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However, when the best conditions from Table 4 (entry 1) were 
applied to the arylpalladation reaction with a tetrahydro-
pyranyl ether protected alcohol, absolutely none of the 
desired compound could be isolated. Only the starting 
materials were recovered. Changing the reaction conditions 
only led to the destruction of starting materials (eg. 11). 
OTHP 8% PdCPPh^)^ 
+ HC=C»C<C_H 5 11 NaOAc 
H A 
0_ /CO^CH 
0% 
OTHP 
( 1 1 )  
+ starting materials 
It was thought that an electron-donating group like an ether 
group might be inhibiting the oxidative addition of the aryl 
halide to the electron-rich palladium(O) complex (eg. 12). 
RO- •X + PdL, RO-V V—+ 2L 
L  ( 1 2 )  
It is reasonable that an electron-rich palladium complex would 
rather attack an electron-poor carbon-halide bond. In order 
to ascertain whether electron donation by resonance is 
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actually impeding the progress of the first step, it was 
envisioned that the ether group meta to the halogen might 
change the trend. Hence, it was decided to attempt aryl-
palladation reactions using methyl m-bromophenoxyacetate. The 
synthesis of this ester was accomplished using a literature 
, , 65,66 procedure (eg. 13). 
ClCHgCOgH 
NaOH 
^2° 
reflux 
12 hours 
Br. CCUH 
V 
88% 
Br. 
MeOH 
HzSO, 
reflux 
6 hours 
.0 COgCHg 
78 89% 
(13) 
Upon treating norbornene, (S)-l-octyn-3-ol and the aryl 
halide 2£ with Pd(PPh2)^ catalyst and one equivalent of sodium 
acetate in anisole at 80°C for a period of 40 hours, it was 
observed that the expected product 79. obtained in a very 
poor yield (6%) (eg. 14). Since both the aryl halide and the 
starting alcohol had the same Rg on TLC, they could not be 
separated from one another. Moreover, impurities prevented 
clean isolation of starting materials. Varying the reaction 
conditions had no effect on the yield of the reaction. Higher 
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Br CO2CH3 I OH 
+ HC = Ck&CcH, . 
r 5 11 
H 
4 
8% Pd(PPh,) 
NaOAc 
80°C 
40 hours 
anisole 
(14) 
OH 
6% 79 
temperatures gave no product at all. Switching to the more 
reactive iodoarene worsened the reaction. In those reactions, 
absolutely no product could be isolated. The reaction time 
made no difference either. Lengthening the reaction time led 
to no product at all. 
Changing the substituent para to the halogen in the arene 
seemed to be the only reasonable way to solve the problem. 
This time the role of an acetate group was examined. The 
readily available p-bromo and p-iodophenylacetates were then 
subjected to the arylpalladation reaction. When norbornene, 
(four equivalents), p-iodophenylacetate and racemic 1-octyn-
3-0I were reacted with PdfPPhg)^ (8%) and one equivalent of 
sodium acetate in anisole at 80°C, very little of the expected 
product ^  was obtained (8%) (eg. 15). In the case of 
£-bromophenylacetate, no product could be seen. Only starting 
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4 u + X OAc + HC=CCHC^H I 5 I 11 8% PdtPPh])^ > 
X = Br, I 
OH NaOAc 
80°C 
one day 
anisole 
(/ \>-OAc (15) 
+ X OAc 
OH 
^ X = I 8% 
X = Br 0% 
X = Br 54% 
X = I 45% 
material was isolated. In both cases the reaction was stopped 
after 24 hours as it started to turn to tar. When the same 
reactions were repeated using the tetrahydropyranyl (THP) 
ether protected alcohol, absolutely no products were isolated. 
Only starting materials were recovered. Extended reaction 
times also led to formation of tar. 
As the amounts of compounds 11_, 22 ^rid 80_ obtained from 
the arylpalladation reactions were very small, their 
structures were determined based entirely on proton NMR- IR 
and mass spectral data. Also, the spectra obtained were 
compared with those of known compounds possessing similar 
structures.®^ The three compounds are numbered in the 
following manner for spectral assignment (Fig. 6). 
The NMR spectra of all three compounds showed patterns 
characteristic of cis-di-exo substituted products. The two 
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I 7 
5 
/SfO' 3 
OH OH 
77 79 
OH 
80 
Figure 6. Numbering system 
endo hydrogens HC(2) and HC(3) revealed the splitting of an AB 
system. The two doublets for HC(2) and HC(3) were seen at ô 
2.92 (J = 8.7 Hz) and 6 2.82 (J = 8.7 Hz) respectively for 
compound 22." In the case of compound 7£/ the two overlapping 
AB doublets were seen at 6 2.61 with J = 9 Hz for HC(2) and 
HC(3). The two AB doublets for compound _8£, however, were 
seen at 6 2.98 [HC(3), J = 9 Hz] and 6 2.85 [HC(2), J = 9 Hz] 
respectively. The coupling constants for cis-endo hydrogens 
in these systems usually range from 8-11 Hz.^^ The HC(1) 
proton was seen as a closely spaced doublet (J = 1.5 Hz at 6 
2.51) and HC(4) was a broad singlet at S 2.41 for compound 77. 
In the case of compound 79.' HC(1) and HC(4) were singlets at 6 
2.55 and 6 2.41 respectively. The HC(1) and HC(4) absorptions 
for compound ^  were singlets at S 2.57 and S 2.41. Exact 
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mass data for compound 77_ and IR data (hydroxyl and ester 
absorptions) added further confirmation to the structure of 
the compound. Similarly, exact mass and IR data confirmed the 
structural assignments for compounds 7_9 and £0. The NMR 
spectra of these compounds could not be obtained as only very 
small amounts of material were in hand. 
Some of the salient features in the synthetic approach to 
interphenylene PGH analogs can be summarized as follows. The 
two side chains (aryl or benzyl) and the terminal alkyne are 
introduced to a symmetric bridged bicyclic olefin in one step 
stereoselectively. These reactions make use of readily 
available starting materials and catalytic amounts of a 
palladium(O) complex. Though the arylpalladation reactions 
were not successful, the benzylpalladation reactions afforded 
an entry into the interphenylene PGH analog systems. This 
approach not only tolerates different functional groups 
(alcohols and esters), but introduces both the side chains in 
their entirety in one step, stereoselectively. Judging from 
the complexity of the molecules that have been synthesized, it 
can be inferred that employing other routes to these systems 
would mean more reaction steps and less elegance. Moreover, 
the stereochemistry of the two side chains (cis-exo) could be 
very difficult to introduce using normal synthetic routes such 
as the Diels-Alder reaction. 
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Other attempted approaches to PGH^ analogs The 
benzylpalladation approach which was successful in the 
synthesis of interphenylene PGH analogs, in theory, should be 
applicable to the synthesis of PGHg analogs (such as compound 
82) provided the benzyl halide is substituted by an alkyl or a 
vinyl halide. The scheme involving the use of allyl halides 
is outlined below (Scheme 11). It was envisioned that the 
Scheme 11 
I'D OH NaOAc 
X = CI, Br, I & 
co^H Os/MejS 
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bicyclic adduct ^  could be obtained by treating norbornene, 
with an allyl halide and (S)-l-octyn-3-ol in the presence of 
catalytic amounts of ^^(PPhg)^ and one equivalent of sodium 
acetate in anisole at 80®C. Selective ozonolysis of the 
olefinic bond in 8^^ to the corresponding aldehyde, followed by 
a Wittig olefination would yield the PGHg analog This 
straightforward strategy, however, was not successful in the 
laboratory. 
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Thus, treatment of allyl chloride and racemic l-octyn-3-ol-
with norbornene (four equivalents) in the presence of 
PdfPPhg)^ (8%) and sodium acetate in anisole at 80-C did not 
provide the anticipated product; only starting material 
(alcohol) was recovered. Switching to the more reactive 
halides/ such as allyl bromide and allyl iodide, gave no 
improvement, as these reactions yielded many products. Allyl 
acetate was then substituted for the allyl halides in the 
above reaction. Even then, the reaction yielded many 
products. Protecting the alcoholic moiety in the starting 
alkyne also resulted in no success. Lowering the temperature 
in all of the above reactions yielded only unreacted starting 
materials. 
At this stage, it was conceived that a vinyl ether group 
would be a better precursor to the aldehyde 83_. The synthesis 
of compound ^  using a haloenol ether is depicted in the 
following scheme (Scheme 12). The bicyclic vinyl ether adduct 
which could be obtained from the palladium addition reaction 
could then be subjected to acid hydrolysis to yield the 
intermediate aldehyde which upon Wittig olefination would 
yield the desired analog Unfortunately, when cis-2-bromo-
ethoxyethylene, racemic l-octyn-3-ol and norbornene (four 
equivalents) were heated to 80°C in the presence of catalytic 
amounts of ^^(PPhg)^ and sodium acetate in anisole at 80°C, 
many products were obtained. When the same reaction was 
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Scheme 12 
OR 
f + HCsCCHCgH^^ 
OH 
( cc:"" 
R = alkyl group 
X = halogen 
H3O 
OH §1 
Wittig 
V 
8 2  
8% PdtPPh])^ 
NaOAc 
A 
carried out at room temperature, the vinyl-alkyne coupled 
product was isolated in a very high yield; no trace of the 
desired bicyclic adduct could be observed (eq. 16). 
/—\ 
Br 
8% PdXPPhg)^ 
NaOAc 
anisole 
room temperature 
OEt 
+ HCsCCHCrH.T I 3 11 
OH 
/ \ 
EtO CEC-CHC^H I 
OH 
5 11 
91% 
( 1 6 )  
Increasing the amount of norbornene (20 equivalents) did not 
change the course of the reaction, when vinyl bromide was 
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used instead of the bromovinyl ether, only the starting 
alcohol was isolated both at room temperature and at 80°C, 
Another approach to the aldehyde ^  is via the following 
scheme (Scheme 13). 
Scheme 13 
[ 8% Pd(PPh.). 
4 ! + XCH2CO2R + HCsC-CHC^H^^ 3 4^ 
X = Br. I NaOAc 
A 
CC" DIBAL I 
I 
OH 
83 
When ethyl iodoacetate, racemic l-octyn-3-ol, norbornene 
(four equivalents), sodium acetate and catalytic amounts of 
PdfPPhg)^ were heated at 80°C in anisole, none of the desired 
product was isolated. Instead, many products were observed 
upon analysis by TLC, Conducting the same reaction at a lower 
temperature, or using ethyl bromoacetate instead of the 
corresponding iodo compound, had no impact on the nature of 
the reaction. 
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Thus, the catalytic palladium approaches outlined above 
were not successful in the synthesis of PGHg analogs. The 
reason for the lack of success in the desired addition 
reaction is not apparent. 
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EXPERIMENTAL SECTION 
Equipment 
Proton NMR spectra were recorded on either an EM-360 or a 
Nicolet NT-300 spectrometer. NMR spectra were recorded on 
either a JEOL-FX900 or Nicolet NT-300 (operating at 75 MHz for 
carbon nuclei) spectrometer. Infrared spectra were recorded 
on a Beckman-42050 spectrophotometer. Mass spectral data were 
obtained on an MS-50 high resolution mass spectrometer. 
Reagents 
All chemicals were used directly as obtained commercially 
unless otherwise noted. Anisole was distilled over sodium 
under reduced pressure. Acetone was distilled over potassium 
carbonate and used immediately. N,N-Dimethylformamide (DMF) 
was distilled over calcium hydride. Methanol was distilled 
over magnesium raethoxide. 7-Oxabicyclo[2.2.1]heptene was 
prepared using a literature procedure.Tetrakis(triphenyl-
phosphine)palladium(O) [PdtPPh^)^] was prepared by the method 
of Coulson.^^ Compound 7^, £-iodo and ^ -bromophenoxyacetic-
acid methyl esters were made by methods reported in the 
literature. 
Preparation of methyl 3-(chloromethyl)phenoxyacetate 68 
Compound was prepared in three steps starting from 
m-hydroxybenzaldehyde (Aldrich). To a stirred solution of 
m-hydroxybenzaldehyde (1.32 g, 10 mmol) and potassium 
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carbonate (1.40 g, 10 mmol) in acetone was added methyl bromo-
acetate (1.52 g, 10 nunol) under nitrogen. The mixture was 
refluxed for 12 h, by which time the reaction mixture turned 
lighter and potassium bromide was observed to precipitate. 
After having cooled, the mixture was poured into water and 
extracted with ether. The extracts were then dried over 
sodium sulfate and concentrated on a rotary evaporator to 
yield the crude product. Vacuum distillation (0.2 mm Hg at 
125°C) yielded the pure product 69^ (1.7 g, 88% yield) as a 
colorless oil which turns yellow on exposure to air; NMR 
(CDClg) 5 3.70 (3 H, s, OCH3), 4.60 (2 H, s, OCHgCOg), 
7.20-7.70 (4 H, m, aryl), 9.90 (1 H, s, CHO); IR (neat) 2700 
(HC=0), 1760 (Me0c=0) cm"^; MS, m/z 194.05739; calcd for 
C10H10O4, 194.05791. 
To a flame dried, round bottom flask was added sodium 
borohydride (0.52 g, 13.6 mmol) and methanol (20 mL). The 
mixture was stirred at room temperature for a few min and then 
cooled to 0°C. The formyl ester 2 (2.4 g, 12.4 mmol) 
dissolved in methanol (20 mL) was added to the sodium boro­
hydride solution with stirring, while backflushing with 
nitrogen. After 30 min, another portion of sodium borohydride 
(0.24 g, 6.2 mmol) was added. The reaction, as indicated by 
TLC, was complete within five min. The reaction mixture was 
then quenched at 0°C with dilute HCl and extracted with ether. 
The aqueous washings were extracted with ether and the 
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combined extracts were dried over sodium sulfate. Removal of 
the solvent under vacuum yielded the colorless, oily hydroxy 
ester 22 almost quantitative yield (2.42 q). The virtually 
pure alcohol was used without further purification. NMR 
(CDCI3) 6 2.70 (1 H, br s, OH), 3.75 (3 H, s, OCH^), 4.6 (4 H, 
s, ArCHg and OCHgCOg), 6.7-7.6 (4 H, m, aryl); IR (thin film) 
3700 (OH), 1750 (C=0) cm~^; MS, m/z 196.07306; calcd for 
C10H12O4, 196.07356. 
To a stirred mixture of this alcohol 22. (2.4 g, 12.3 mmol) 
and s-collidine (1.64 g, 13.5 mmol) under nitrogen was added 
lithium chloride (0.57 g, 13.5 mmol) dissolved in a minimum 
amount of dry DMF. On cooling to 0°C, a suspension was formed 
which was treated with methanesulfonyl chloride (1.54 g, 13.5 
mmol). Stirring was continued for 2 h and the reaction 
mixture was then poured into ice. The aqueous layer was 
extracted with cold 1:1 ether/pentane and the combined 
extracts were washed with saturated copper nitrate solution 
until no further intensification of the blue copper solution 
occurred; indicating complete removal of s-collidine. The 
organic extracts were dried over sodium sulfate and concen­
trated to yield the crude halide Further purification by 
column chromatography using 2:1 hexanes/ethyl acetate as 
eluent yielded 2.15 g (82%) of pure R^ 0.51, 2:1 
hexanes/ethyl acetate; ^H NMR (CDClg) 6 3.82 (3 H, s, OCH^), 
4.62 (2 H, s, ClCHg), 4.70 (2 H, s, OCHgCOg), 6.80-7.42 (4 H, 
m, aryl); IR (neat) 1760 (C=0) cm ^; MS, m/z 214.03866; calcd 
Eor CigH^^ClOg, 214.03968. 
Resolution of l-octyn-3-ol 
l-Octyn-3-ol was resolved via crystallization of the 
ammonium salt of its half phthalate ester prepared as 
41 follows. Phthalic anhydride (74 g, 0.5 mole) was added to 
l-octyn-3-ol (63.1 g, 0.5 mole) (Aldrich) and was heated with 
stirring at 165-170°C for 21 h under nitrogen. After cooling 
to 60°C, benzene (100 ml) was added. After the addition of 
200 ml of hexanes, the mixture was stirred at 0°C for 4 h. 
Filtration yielded a white solid which was washed with 
hexanes. The solid was dried under reduced pressure. The 
half phthalate ester 71_ (75 g, 0.275 mole) with a melting 
point of 70-71°C was obtained in 55% yield. 
After dissolving the solid (75 g) in benzene (100 mL) at 
60°C, hexanes (200 mL) was added to the solution. The 
solution was then stirred at 0°C for 3 h. After filtration, 
the white solid was dried under reduced pressure at 50°C for 3 
h. The half phthalate ester was obtained as a white solid in 
92% yield (69.2 g), rap 71-73°C. 
This solid was again crystallized from benzene (110 mL) 
and hexanes (180 mL) to afford the half phthalate ester in 63% 
yield (44 g), mp 76-77°C (lit.^^ mp 76-77°C). 
The half phthalate ester was then converted to its amine 
salt as follows. (S)-(-)-a-Phenethyl amine (19.4 g, 0.16 
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mole) (Aldrich) was added dropwise via a- syringe to a 
suspension of the half phthalate ester 7_1 (44 g, 0.16 mole) in 
CHgClg (36 mL) under reflux and stirred for 30 min. A small 
amount of amine salt as a seed was added to the solution, 
after cooling. The reaction mixture was then allowed to stand 
in a freezer overnight and the crystals formed were collected, 
washed with acetone, and dried under reduced pressure at room 
temperature. The first crop (20 g, 31% yield) was then added 
to CHgClg (45 mL) and the mixture was refluxed with stirring 
for 30 min. After complete dissolution of the solid, the 
clear solution was allowed to cool to room temperature. A few 
seed crystals were added and the solution was kept in a 
freezer overnight. The crystals were filtered, washed with 
CHgClg (10 mL), and dried under vacuum at room temperature 
(12.42 g, 62% yield; mp 133-136°C). Two further recrystal-
lizations furnished material with a melting point of 135-136°C 
(lit.G3 mp 133.5-135°C). 
The optical purity of the amine salt could be monitored by 
NMR spectral analysis» The acetylenic hydrogen doublets 
for the two diastereomers appear at 6 2.48 (S-S) and S 2.52 
(R-S). Only the former peak was present in the NMR 
spectrum of the above thrice recrystallized salt. 
(S)-l-0ctyn-3-ol (72_) was isolated as follows. The 
(S-S)-amine salt (9.58 g, mp 135-136°C) was added to 10% NaOH 
(55 mL) and the solution stirred at 60°C for 1 h. After 
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cooling to room temperature, the solution was extracted three 
times with CHgClg (100 mL). The combined extracts were 
successively washed with IN HCl, concentrated HCl (7 mL in 20 
mL of water), brine, saturated sodium bicarbonate, and brine, 
and dried over sodium sulfate. After removal of the solvent, 
the residue was distilled to give pure (S)-l-octyn-3-ol (2.69 
g) as a colorless oil in 88% yield; bp 88-89°C, -20 mm Hg; 
CHClg = -6.79° (literature^^ = -5.5° and 
= 6.5). 
The NMR spectrum of (S)-l-octyn-3-ol (8 mg) with 
Eu(hfbc)2 (14 mg) in 0.3 mL of CDCl^ indicated a broadened 
singlet at ç 7.81 corresponding to the hydrogen alpha to the 
hydroxy group. A singlet corresponding to the R-isomer 
(usually about 0.3 ppm downfield relative to the S-isomer) was 
not observed. Hence, the alcohol obtained is "100% optically 
pure. 
Synthesis of compounds 6_7, 73.' 2A' 22.' 22 ^nd 
The procedure for the synthesis of compound ^  is 
representative of that used to prepare all of the above 
compounds. To a round bottom flask with a sidearm equipped 
with a reflux condenser was introduced, under nitrogen, 
Pd(PPh2)^ (45 mg, 0.039 mmol) and anhydrous sodium acetate (41 
mg, 0.5 mmol). A solution of distilled benzyl chloride (64 
mg, 0.5 mmol), racemic l-octyn-3-ol (63 mg, 0.5 mmol), and 
norbornene (188 mg, 2 mmol) (Aldrich) in degassed anisole (1 
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ml) was added to the flask. The mixture was heated at 70 "C 
for approximately 24 h. After cooling, dilute sulfuric acid 
was added and the solution was extracted with diethyl ether. 
After drying the ether extracts over anhydrous sodium sulfate, 
the solvents were removed under vacuum and the residue 
chromatographed on a silica gel column using hexanes/ethy1 
acetate mixtures as the eluent. The expected product ^  was 
isolated in 81% yield (126 mg): 0.48, 5:1 hexanes/ethy1 
acetate; NMR (CDCl^) ô 0.88-2.20 (19 H, m, aliphatic and 
OH), 2.85 (1 H, d, J = 13 Hz, HC(2)), 3.12 (2 H, m, ArCHg), 
4.45 (1 H, m, CHOH), 7.30 (5 H, m, aryl); NMR (CDCI3) 6 
142.35, 128.95, 128.24, 125.64 (all aryl), 86.80 and 83.75 
(C=C), 62.68 (CHOH), 46.63, 45.00, 39.80, 39.08, 38.24, 33.82, 
31.54, 29.91, 28.48, 24.97, 22.63, 14.05 (all aliphatic); IR 
(neat) 3360 (OH) cm ^; MS, m/z 310.2287; calcd for C22H3QO, 
310.2282. 
Compound 53% yield; R^ 0.48, 5:1 hexanes/ethyl 
acetate; ^H NMR (CDCl^) 6 1.05-2.21 (17 H, m, aliphatic and 
OH), 2.88 (1 H, d, J = 14 Hz, HC(2)), 3.35 (2 H, m, ArCH,), 
4.68 (1 H, m, CHOH), 6.38 (2 H, br s, vinylic), 7.55 (5 H, m, 
aryl). In addition, the following signals were seen (possibly 
from the accompanying impurity); 0 2.5 (m), 2.76 (m), 5.2 (br 
m), 5.6 (s); ^ ^C NMR (CDCI3) 6 141.64, 138.53, 135.10, 128.89, 
128.21, 125.72 (all aryl), 87.02 and 83.66 (C=C), 62.82 
(CHOH), 49.95, 48.50, 47.20, 45.22, 43.61, 42.61, 39.43, 
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38 .24 ,  34.45, 32.50, 31.50, 24.94, 22.54, 13.61 (aliphatic) 
(the extraneous carbon absorptions are from the accompanying 
impurity); IR (neat) 3350 (OH) cm MS, m/z 290.2040; calcd 
for (M-18), 290.2039. 
Compound 7_3; 58% yield; Rg 0.33, 3:1 hexanes/ethyl 
acetate; NMR (CDCl^) 6 0.85-1.75 (18 H, m, aliphatic and 
OH), 1.86 (1 H, br t, J = 9.6 Hz, endo HC(3)), 1.97 (1 H, m, 
HC(4)), 2.29-2.35 (1 H, m, HC(1)), 2.42 (1 H, dd, J = 10.6 Hz, 
J = 10.5 Hz, diastereotopic ArCH), 2.62 (1 H, d, J = 10.7 Hz, 
endo HC(2)), 2.86 (1 H, br dd, J = 14.4 Hz, J = 5.1 Hz, 
diastereotopic ArCH), 3.85 (3 H, s, OCHg), 4.29-4.41 (1 H, m, 
CHOH), 4.70 (2 H, s, OCHgCOg), 6.72 and 6.73 (1 H, d, J = 7.8 
Hz, aryl, diastereomers), 6.79 (1 H, s, aryl), 6.85 (1 H, d, J 
= 7.5 Hz, aryl), 7.20 (1 H, t, J = 7.7 Hz, aryl). Irradiation 
of the proton giving rise to the peak at 6 2.86 causes the 
peak at 6 1.86 to collapse to a broad triplet (^ = 6 Hz) and 
the peak at s 2.42 collapses to a doublet (J = 8.3 Hz). 
Irradiation of the proton giving rise to the peak at 5 2.62 
causes the peak at 6 1.86 to collapse to a simplified 
multiplet. Irradiation of the proton giving rise to the peak 
at 6 2.42 causes the peak at 6 2.86 to collapse to a singlet 
and the peak at 6 1.86 remains the same. Irradiation of the 
proton giving rise to the multiplet at o 2.29-2.35 causes no 
change except for a sharpening of the peak at 6 1.86. 
Irradiation of the proton giving rise to the multiplet at ô 
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1.97 causes the peak at S 2.62 to collapse to a singlet; the 
peaks at 6 2.86 and 2.42 are now doublets with J = 13.7 Hz and 
14.5 Hz respectively, and the multiplet at ô 1.97 is a sharp 
singlet. NMR (CDCI3) Ô 169.49 (C=0), 157.72, 144.19, 
129.15, 122.52, 115.66, 111.39 (all aryl), 86.57 and 83.79 
(C C), 65.32 (OCHg), 62.79 (CHOH), 52.22 (OCH3), 46.42, 44.93, 
39.85, 39.04, 38.95, 38.17, 33.77, 31.47, 29.82, 28.40, 24.97, 
22.58, 14.00 (aliphatic); IR (neat) 3500 (OH), 1760 (C=0) 
cm ^; MS, m/z 398.2457; calcd for ^25^35*^4' 398.24644. 
Compound T4: 37% yield; Rg 0.33, 3:1 hexanes/ethyl 
acetate; NMR (CDCl^) 0.85-1.86 (13 H, m, aliphatic and 
OH), 2.43-2.48 (2 H, m, HC(4) and diastereotopic ArCH), 2.53 
(1 H, d, J = 9.0 Hz, HC(2)), 2.91 (1 H, br s, HC(1)), 3.10 (1 
H, dd, J = 13 Hz, ^  = 5.1 Hz, diastereotopic ArCH), 3.83 (3 H, 
s, OCH3), 4.38 (1 H, m, CHOH), 4.66 (2 H, s, OCHgCOg), 6.07 (2 
H, br s, vinylic), 6.73 (1 H, dd, J = 5.3 Hz, J = 2 Hz, aryl), 
6.79 (1 H, s, aryl), 7.24 (1 H, d, J = 6 Hz, aryl), 7.24 (1 H, 
dd, J = 7.0 Hz, aryl); ^^C (NMR) 6 169.50 (C=0), 157.77, 
145.97, 138.50, 135.65, 129.25, 122.52 (all aryl), 115.68, 
111.52 (C=C), 87.19 and 83.69 (C C), 65.33 (OCHgCOg), 62.76 
(CHOH), 52.21 (OCH3), 50.24, 45.26, 43.61, 42.53, 39.40, 38.24 
and 38.17 (diastereomeric), 34.35, 31.47, 24.96, 22.60, 14.00 
(all aliphatic); IR (neat) 3420 (OH), 1750 (C=0) cm~^; MS m/z 
396.2296; calcd for CggH^^O^, 396.2301. 
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Compound 75.: 45% yield; 0.55, 1:1 hexanes/ethyl 
acetate; NMR (CDCl^) 6 0.86-1.80 (16 H, m, aliphatic and 
OH), 2.06-2.19 (1 H, m, endo HC{3)), 2.57 and 2.62 (1 H, dd, J 
= 10.8 Hz, J = 3 Hz, diastereotopic ArCH), 2.86 (1 H, d, J = 
8.4 Hz, endo HC(2)), 2.83-2.89 (1 H, m, diastereotopic ArCH, 
buried under doublet of HC(2)), 3.81 (3 H, s, OCH^), 4.26 (1 
H, d, J = 5.6 Hz, HC(4)), 4.36-4.38 (1 H, m, CHOH), 4.55 (1 H, 
d, J = 4.2 Hz, HC(1)), 4.64 (2 H, s, OCHgCOg), 6.70 and 6.72 
(1 H, d, J = 8.1 Hz, aryl, diastereomers), 6.79 (1 H, s, 
aryl), 7.22 (1 H, t, J = 8.0 Hz, aryl). Irradiation of the 
proton giving rise to the peak at 6 2.86 causes the multiplet 
at Ô 2.06-2.19 to collapse to a doublet (J = 9.9 Hz). 
Irradiation of the proton giving rise to the peaks at 2.57 
and 6 2.62 causes the multiplet at ô 2.83-2.89 to collapse to 
a simplified multiplet; the multiplet at 5 2.06-2.19 also 
collapses to a simplified multiplet. Irradiation of the 
proton giving rise to the peak at ô 2.06-2.19 causes changes 
in multiplicity at 6 2.57-2.62; ^^C NMR (CDClg) 6 169.47 
(C=0), 157.94, 143.29, 129.51, 122.61, 115.70, 111.87 (all 
aryl), 84.65 and 84.34 (C C), 82.95 and 79.06 (C^ and C^), 
79.00 (C^ or C^, diastereomeric), 65.37 (OCHg), 62.72 (CHOH), 
52.24 (OCHg), 48.24, 40.30, 38.08, 37.69, 31.48, 29.31, 29.18, 
24.94, 22.58, 14.00 (all aliphatic); IR (neat) 3420 (OH), 1760 
(C=0) cm"^; MS, m/z 400.22409; calcd for Cg^H^gOg, 400.22408. 
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Compound 7£ and its diastereomer were also isolated from 
the above reaction (for numbering see Fig. 5): Rg 0.33, 1:1 
hexanes/ethyl acetate; NMR (CDCl^) 6 0.83-1.78 (20 H, m, 
aliphatic and OH), 2.00 (1 H, br t, J = 8.8 Hz, endo HC(3)), 
2.14 (1 H, br t, J = 9.1 Hz, endo HC(2')), 2.15-2.28 (1 H, m, 
endo HC(3'), buried under the triplet at s 2.14), 2.39 (1 H, 
br t, J = 12.5 Hz, ArCH), 2.68 (1 H, br d, J = 12.8 Hz, ArCH), 
2.80 (1 H, d, J = 8.3 Hz, endo HC(2)), 3.79 (3 H, s, OCH^), 
4.18 (1 H, m, HC(1)), 4.41 (1 H, m, CH^OH) , 4.49-4.56 (3 H, m, 
HC(1', 4' and 4)), 4.63 (2 H, s, OCHgCOg), 6.70-6.75 (1 H, m, 
aryl), 6.80-6.88 (2 H, m, aryl), 7.19 (1 H, t, J = 7.6 Hz, 
aryl); NMR (CDCl^) 5 169.66 (C=0), 158.04, 143.77, 129.50, 
122.72, 115.63, 112.17 (all aryl), 85.68 and 83.95 (C=C), 
82.82, 80.59, 80.16, 79.32, 65.48, 62.86, 52.31, 49.72, 49.17, 
48.91, 41.93, 38.27, 35.74, 31.63, 31.57, 30.82, 30.05, 29.73, 
25.16, 25.07, 22.67 and 14.10 (all aliphatic); IR (neat) 3480 
(OH), 1760 (C=0) cm"""; MS, m/z 496.28382; calcd for C^pH^gOg, 
496.28250. 
Synthesis of compounds 59_, ^  and ^  
The procedure for the hydrolysis of compound 7_3 to 
compound is representative. Hydroxy ester 22 (55.7 mg, 
0,14 mmol) was refluxed for 2 h in 5 mL of methanol and 1 mL 
of 2M KOH. After cooling, the reaction was diluted with 
ether, acidified with 25 ml of 2N sulfuric acid, washed with 
50 ml of brine, and dried over sodium sulfate. Removal of the 
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solvent under vacuum and purification of the residue by 
chromatography using 20:20:1 hexanes/ethyl acetate/glacial 
acetic acid yielded the pure acid ^  as a colorless oil; 95% 
yield; 0,31, 20:20:1 hexanes/ethyl acetate/glacial acetic 
acid; NMR {CDCI3) 6 0.86-1.93 (18 H, m, alkyl), 1.98 (1 H, 
m, endo HC(3)), 2.1 (1 H, s, OH), 2.34 (1 H, m, HC(1)), 2.46 
(1 H, dd, J = 10.2 Hz, diastereotopic ArCH), 2.62 (1 H, d, J = 
8.0 Hz, endo HC(2)), 2.88 (1 H, br d, J = 9.3 Hz, diastereo­
topic ArCH), 4,36 (1 H, m, CHOH), 4.66 (2 H, s, OCHgCOg), 4.95 
(1 H, s, COgH), 6.73 (1 H, d, J = 7.6 Hz, aryl), 6.79 (1 H, s, 
aryl), 6.85 (1 H, d, J = 7.5 Hz, aryl), 7.21 (1 H, t, J = 7.8 
Hz, aryl); NMR (CDCI3) ô 157.53, 144.30, 129.28, 122.68, 
115.66 and 115.59 (diastereomeric), 111.60 (all aryl), 86.93 
and 83.50 (C C), 62,98 (CHOH), 46.42, 46.36, 45.02, 40.16, 
39.13 and 39.06 (broadened, diastereomeric), 38.98, 33.90, 
31.50, 29.92, 28.42, 24.98, 22.64, 14.04; IR (neat) 3600-2700 
(OH, COgH), 1740 (C=0) cm""; MS, m/z 384.23007; calcd for 
C24H32O4, 384.23000. Anal. Calcd. for Cg^H^gO^: C, 75.02; H, 
8.39. Found: C, 75.03; H, 8.30. 
Compound 62% 88% yield; R^ 0.30, 20:20:1 hexanes/ethyl 
acetate/acetic acid; ^H NMR (CDCl^) 6 0.83-1.89 (15 H, m, 
aliphatic and OH), 2.49-2.55 (3 H, m, diastereotopic ArCH and 
norbornyl HC(2) and HC(4)), 2.91 (1 H, s, HC(1)), 3.10 (1 H, 
br d, J = 15 Hz, ArCH), 4.38 (1 H, m, CHOH), 4.66 (2 H, s, 
OCHgCOg), 5.36 (1 H, br s, COgH), 6.06 (2 H, br s, vinylic), 
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6.75 (1 H, br d, J = 8.7 Hz, aryl), 6.79 (1 H, s, aryl), 6.85 
(1 H, d, J = 7.6 Hz, aryl), 7.21 (1 H, t, J = 7.8 Hz, aryl); 
NMR (CDCI3) ô 157.57, 144.05, 138.56, 135.66, 129.32, 
122.62, 115.64 (ail aryl), 115.56 and 111.76 (C=C), 87.53 and 
83.38 (C C), 65.42 (OCH^), 63.00 (CHOH), 50.30, 45.67 and 
45.62 (diastereomeric), 43.70, 42.53, 42.44, 39.40, 38.13 and 
38.08 (diastereomeric), 34.41, 31.47, 24.96, 22.61, 14.01 (ail 
aliphatic); IR (neat) 3500-2700 (OH, COgH), 1735 (C=0) cm~^; 
MS, m/z 382.21479, calcd for 382.21442. Anal. Calcd 
for *^24^30*^4' 75.40; H, 7.90. Found: C, 75.19; H, 7.85. 
Compound ^  was prepared by the same basic procedure 
described above except that the reaction was run at room 
temperature for two days: 98% yield; Rg 0.31, 20:20:1 
hexanes/ethyl acetate/glacial acetic acid; ^H NMR (CDClg) 5 
0.86-1.80 (16 H, m, aliphatic and OH), 2.06-2.20 (1 H, m, endo 
HC(3)), 2.62 (1 H, t, J = 13.8 Hz, diastereotopic ArCH), 
2.84-2.90 (2 H, m, diastereotopic ArCH, buried under the 
doublet of HC(2)), 4.28 (1- H, d, J = 4.2 Hz, HC(4)), 4.36 (1 
H, br t, J = 6.3 Hz, CHOH), 4.57 (1 H, d, J = 3.9 Hz, HC(1)), 
4.66 (3 H, s, broadened at the base, OCHgCOg and COjH), 6.76 
(1 H, d, J = 7.8 Hz, aryl), 6.80 (1 H, s, aryl), 6.86 (1 H, d, 
J = 7.8 Hz, aryl), 7.22 (1 H, t, J= 8.1 Hz, aryl); ^^C NMR 
(CDCI3) Ô 157.75, 143.38, 129.63, 122.80, 115.78 and 115.72 
(diastereomeric), 112.26 (all aryl), 84.69 and 84.50 (C C), 
83.10 and 79.39 (C^ and C^), 65.17 (OCHg), 62.90 (CHOH), 
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48.23, 40.43, 38.10, 37.72, 31.54, 29.34, 29.28, 14.00 (all 
aliphatic); IR (neat) 3600-2700 (HO, COgH), 1740 (C=0) cm"^; 
MS, m/z 386.2093, calcd for ^23^30^5' 386.2099. Anal. Calcd 
for CggHggOg: C, 71.46; H, 7.76. Found: C, 69.43; H, 7.84. 
Compound 2Z* 11% yield; R^ 0.33, 4:1 hexanes/ethyl 
acetate; ^H NMR (CDCl^) 6 0.85-1.67 (16 H, m, aliphatic), 2.00 
(1 H, br d, J = 11.1 Hz, HC(7) , syn to the two side chains), 
2.41 (1 H, br s, HC(4)), 2.51 (1 H, d, J = 1.5 Hz, HC{1)), 
2.82 (1 H, d, J = 8.7 Hz, HC(3) endo), 2.92 (1 H, d, J = 8.7 
Hz, HC(2) endo), 3.79 (3 H, s, OCH^), 3.81 (1 H, s, OH), 3.97 
(1 H, m, CHOH), 4.61 (2 H, s, OCHgCOg), 6.82 (2 H, ABd, J = 
^ OR' 
8.5 Hz, 7.14 (2 H, ABd, J = 8.5 Hz, ); IR 
OR' R 
(neat) 3450 (OH), 1750, (C=0) cm ^; MS, m/z calcd for 
C24^32°4' 384.2285, found 384.2293. 
Compound 79.- 6% yield; Rg 0.35, 3:1 hexanes/ethyl 
acetate; NMR (CDCI3) 6 0.84-1.63 (17 H, m, aliphatic and 
OH), 1.97-2.02 (1 H, m, HC(7), syn to the two side chains), 
2.41 (1 H, br s, HC(4)), 2.55 (1 H, br s, HC(1)), 2.61 (2 H, 
AB system, J = 9 Hz, HC(2) and HC(3) endo), 3.81 (3 H, s, 
OCHg), 3.95 (1 H, m, CHOH), 4.61 (2 H, s, OCHgCOg), 6.70 (1 H, 
d, J = 1 Hz, L ij ) f 6.77 (1 H, s, 1 ), 6.84 (1 H, d, J 
75 
R. 
li i 
= 1 Hz, 7.20 (1 H, dd, J = 15 Hz, J = 4.2 Hz, 
Y ^ , 
, ); IR (neat) 3480 (OH), 1795 (C=0) MS, m/z calcd 
H 
for C24H32O4, 384.2297, found 384.2300. 
Compound £0: 8% yield; R^ 0.34, 5:1 hexanes/ethyl 
acetate; ^H NMR (CDCl^) 6 0.85-1.62 (17 H, m, aliphatic and 
OH), 2.01 (1 H, d, J = 10.5 Hz, aliphatic), 2.28 (3 H, s, 
OCOCH3), 2.41 (1 H, br s, HC(4)), 2.57 (1 H, br s, HC(1)), 
2.85 (1 H, ABd, J = 9 Hz, HC(2) endo), 2.98 (1 H, ABd, J = 9 
Hz, HC(3) endo), 3.96 (1 H, m, CHOH), 6.96 (2 H, d, J = 8.4 
Hz, R-^-oAc), 7.20 (2 H, d, J = 8.4 Hz, ^  ) ; IR (neat) 
H H-
3420 (OH), 1758 (C=0) cm~^; MS, m/z calcd for CggHggOg, 
354.2195, found 354.2195. 
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PART II. ORGANOPALLADIUM APPROACHES TO HETEROCYCLES 
8 2  
INDOLES 
Because of the very potent and diverse biological activity 
exhibited by indole (1^) and its various derivatives, this 
heterocyclic system has been the target of considerable 
attention in chemistry, biology and medicine.^ Indole 
derivatives are essential to both plants and animals. Skatole 
[3-methylindole (^)], which can be isolated from various 
2 
sources, is reported to have antidiuretic and tuberculostatic 
3 
activity. Tryptophan (_3), a naturally occurring amino acid 
is known to inhibit the growth of tuberculosis.*'^ Indole 
acetic acid (£) is a major plant growth hormone^ and 
indomethacin (^) has been reported to have antiinflammatory, 
antipyretic and analgesic activity.^ 
There have been many reported synthetic approaches to 
indoles. The most versatile among these are the Fischer, 
Bischler, Madelung, Reissert, Nenitzescu and Gassman 
procedures and their various modifications.^ It is 
beyond the scope of this discussion to explain in detail the 
aforementioned synthetic approaches. However, a discussion of 
pertinent organometallic approaches to the indole ring system 
will be covered in detail. 
One of the most recent approaches to indoles which 
involved an organometallic reagent was reported by Wender and 
9 10 White. This was based on the work of Oilman et al. It 
involves the successive treatment of 2-bromoaniline (6) with 
83 
5. R 
2 
6 
7 H 
H 
1 2 R = CH^ 
R = CHgCHCNHgiCOgH 
R = CH^COgH 
3 
Cl 4 
CH2CO2H 
5 
methyllithium (two equivalents), pivaloyl chloride (one 
equivalent), and t-butyllithium (two equivalents) to provide 
an organodimetallic intermediate which is subsequently reacted 
with 2-chlorocyclohexanone, followed by base treatment, to 
provide the indole 1_ in good yield (Scheme 1). The advantage 
of this methodology is that all the operations can be 
performed in one pot using commercially available 
2-bromoan iline. 
Studies on free radical mediated carbon-carbon bond 
forming reactions have intensified enormously in recent years. 
Perhaps nowhere has the use of free radical intermediates been 
better exploited than in the synthesis of ring compounds. 
The toleration of many functional groups in this reaction 
84 
Scheme 1 
a; 1. 2 MeLi 2. 1 (CHgjgCCOCl 
3. 2 t-BuLi NLi 
COCfCHj)] 
2-chlorocyclohexanone 
KO-t-Bu 
H^O N H 
COCfCHg) 2 
74% 
makes it very versatile in organic synthesis. A typical 
reaction leading to a dihydroindole system is shown below (eq. 
1). In this reaction an aryl radical, generated from the 
— SPh 
J 
I 
H 
2 equiv. n-Bu_SnH 
— J 
AIBN 
benzene (1) 
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corresponding bromide by tri-n-butyltinhydride, cyclizes and 
the resulting B-phenylethio radical fragments, yielding the 
12 dihydroindole B_ and the phenylthiyl radical. 
The versatility of radical reactions would be enhanced 
still further if practical procedures could be made available 
to introduce functionality during the cyclization by use of 
appropriate radical trapping reagents. This general problem 
has been addressed recently^^ and the use of cobalt(I) 
reagents (from cobaloximes and vitamin in the synthesis 
of ring fused heterocycles by intramolecular cyclization from 
the corresponding aryl halides has been illustrated. It was 
found that N-allyl ,N-methyl iodoaniline (9^) gave 1,3-dimethyl-
indole (3^) in one step (32% yield) on treatment with cobalt 
complex 11 and sodium amalgam (eg. 2). 
PPh, 
11 
( 2 )  
11 
Na/Hg 
CH. 
CH, 
10 325 
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The use of organot-ransition metal complexes in the 
synthesis of heterocyclic compounds has become prevalent in 
recent years. Zerovalent nickel complexes have been used to 
cyclize 2-chloro-N-methyl-N-allylaniline (]^) to 1,3-dimethyl-
indole (10) (eg. The suggested reaction mechanism is 
-CI 
I 
CH. 
12 
1. NitPPhg)^ 
2.  0-
-> 
10 
CH. 
I  
CH-
46? 
(3) 
demonstrated in Scheme 2. Thus, oxidative addition of the 
aryl halide 22 the Ni{0) complex gives rise to the 
Scheme 2 
NitPPhg)^ NiCl^PPhgig 
V 
10 
HNiCKPPh, ) 3'2 
NiClfPPhgig 
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aryl nickel complex which upon addition to the double bond 
generates a a-alkylnickel complex. Hydridonickel elimination, 
followed by double bond migration, yields the heterocycle 10. 
Oxindole derivatives were also synthesized using a similar 
16,17 procedure (eq. 4). 
"^3 f 3 I 
CH, CH 
61% 
18 Rodriguez and Canoira similarly demonstrated the 
application of zerovalent nickel complexes in the synthesis of 
indoles. However, the poor yields of the desired heterocycles 
and the formation of side products (mainly uncyclized, reduced 
starting material) make this approach unattractive. 
19 Castro and co-workers have reported that the addition of 
a cuprous acetylide to 2-iodoaniline produces indoles if the 
reaction is performed in N,N-dimethylformamide, but if 
pyridine is used as the solvent, a mixture of the acetylene 
substitution product and the indole are obtained (eq. 5). 
Heterocyclic synthesis via organopalladium intermediates 
has been explored by several workers. Two types of palladium 
reagents have been used for this purpose, palladium(II) and 
palladium(O). Pd(II) salts involving transmetallation 
reactions will be discussed first. Thus, thallation and 
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DMF 
NH, 
+ = — —-—-—I 
•> 
C5H5" 
H 
•R (5) 
,^ 2 
C = CR 
subsequent palladium-promoted olefination of acetanilide 
provides a novel route to nitrogen heterocycles (Scheme 3). 
21 Hegedus et al. have cyclized 2-allylanilines using a 
palladium(II) salt to prepare indoles (eq. 6). This is a 
NHR 
20 
/ 
NiBr/. 
CH2CH=CH2 
(CH2CN)2PdCl2 
(6) 
V 
89 
Scheme 3 
O .NHAc LigPdCl^ NHAc TlfOgCCF^yg H_,C=CHCH^C1 
typical example of a palladium-mediated intramolecular 
amination of an olefin. A general synthetic approach to the 
pyrrolo-indoloquinone ring system, common to the mitomycin 
antibiotics, was recently developed by Weider et al. (eq. 
7).22 
Similar reactions have been reported to produce polycyclic 
products cleanly.Thus, a-alkylpalladium(II) complexes. 
90 
cat. Pd(II) 
NH^Ph 
arising from intramolecular amine attack and lacking a 
S-hydrogen, insert an olefin and provide a facile 
difunctionalization of olefins in a one-pot procedure that 
potentially catalytic in palladium (eq. 8). 
II Pd(II) 
THF 
L 
Palladium(O)-catalyzed cyclizations leading to indoles 
have been very widely studied. Thus, the intramolecular 
91 
25 
"Heck" arylation of 2-halo-N-allylanilines to 3-methylindole 
26 27 
was examined by Odle et al. ; Hegedus et al; (eg. 9). This 
procedure works 
J 
X = Br, I 
PdtPPhg)^ 
+ Pd(0) 
(9) 
X = Br, 60% 
X = I, 87% 
well for systems in which the side chain olefin is conjugated 
to a carbonyl group. Thus, 2-halo-N-acryloyl or cinnamoyl-
28-30 
anilines are converted to oxindoles using both Pd(0)' 
Ni(0)^^ catalysts (egs. 10, 11). 
Pd{OAc)TP{o-tol), 
— i 
100°C, EtgN 
H 
\ 
-N. 
L 
and 
( 1 0 )  
R = Ph, CH^ R = Ph, 58% 
R = CHg, 21% 
9^ 2^  ^
IL * 
ÇHgPh 
20% 
45% 
+ CH-Ph 
/ 
CN 
( 1 1 )  
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Intramolecular cyclizations of enaminones involving aryl 
palladium complexes was studied by lida et al.^^ The 
cyclization proceeded smoothly to afford carbazoles using both 
catalytic and stoichiometric palladium(O) complexes. A 
typical reaction is shown below (ea. 12). 
0 
PdtOACigtPPhgig 
NaHCO^ 0 ( 1 2 )  1 
R 
Though the intramolecular addition of aryl palladium 
compounds to olefinic bonds leading to heterocycles looks 
attractive, it has a few drawbacks. The product yields in 
most cases are only fair and the temperatures used to induce 
such additions are rather high, often 110 to 130°C. Further­
more, a number of substrates fail to cyclize under those 
reaction conditions. It should be noted, however, that aryl-
palladium intermediates fare better than their arylcobalt or 
arylnickel counterparts. 
The focus of our research was to reexamine the intra­
molecular Heck reaction and to develop feasible reaction 
conditions which would make it more versatile in organic 
synthesis, particularly in the synthesis of heterocycles and 
carbocycles. It was thought that a minor variation of the 
93 
same methodology utilizing milder temperatures would be highly 
desirable. The heterocycles we set out to prepare using this 
approach were indoles (including oxindoles) , guinolines and 
isoquinolines. 
32 33 Recently, Jeffrey ' reported palladium-catalyzed 
addition reactions done under solid-liquid phase transfer 
conditions. The reaction consists of treating a vinyl or an 
aryl iodide and an olefin in the presence of catalytic amounts 
of palladium acetate (1 or 2 mole %), a base (potassium 
carbonate or sodium bicarbonate) and tetra-n-butylammonium 
chloride (phase transfer reagent) in N,N-dimethylformamide 
(DMF) at or near room temperature. A typical reaction done 
under these conditions is represented below (eq. 13). The 
2% Pd(0Ac)2 Ph H 
Phi + 2 H C=CHCO_CH^ > C=C 
NaHCOg ^CO^CH^ (l^) 
n-Bu^NCl 97% 
DMF, RT 
high yields of products obtained in these reactions, in 
addition to the mild temperature employed, make this procedure 
very attractive for synthetic purposes. Employing the same 
solid-liquid phase transfer conditions for intramolecular 
cyclizations, in theory, should yield cyclized products under 
very mild conditions. Also, this procedure might prove 
94 
effective in cases where cyclizations were not achieved 
,  26 previously. 
Results and discussion 
The following compounds 9_, 14a-b, 15-21 were considered 
for cyclization. Compounds 14a-b, 16y 18 and 2^ were prepared 
a. X = I 
b, X = Br 
95 
2 6 by methods reported in the literature. This involves the 
treatment of the ortho-haloaniline with lithium diisopropyl-
amide (LDA) and quenching with the appropriate alkenyl halide 
(eq. 14). Compounds 9 and 20 were made from 14a and 16 in the 
NH. 
1. LDA 
^ if; 95J 
-78-C.RT III 
22, 98% 
presence of LDA and methyl iodide (eq. 15). Compound.1^ was 
1. LDA 
14a or 16 > 9 or 17 
— 2. Mel - "51 
-78°C+RT ^ ° 
THF 
obtained by treating compound 14a with excess acetic anhydride 
at room temperature for two days (eq. 16). Compounds 22 ^nd 
Ac^O 
14a > (16) 
RT, 2 days _ioO% 
20 were obtained by treating ortho-iodoaniline with the 
corresponding acid halide in the presence of triethylamine in 
THF (eq. 17). Compound 21 was made by treating ortho-
(17) 
96 
NH, 
+ RCH=CHC0C1 ^ 
- THF 
RT, 16 hrs 
R = H, Ph 
19 R = H, 80% 
" : 1 (46% recrystallized) 
2^ R = Ph, 94% 
^ ( (73% recrystallized) 
R 
iodoacetanilide with methyl-4-bromocrotonate in the presence 
of sodium hydride (1.4 equivalents) in THF at 0°C (eq. 18). 
1.4 NaH (18) 
> 21 
BrCH2CH=CHC02CH2 335. 
In order to obtain the best conditions for the intramolec­
ular version of the Heck reaction leading to heterocycles, 
compounds 14a and 14b were chosen for model studies. Compound 
14a, in particular, was subjected to a variety of reaction 
conditions. In a typical reaction, compound 14a was treated 
with palladium acetate (2 mole %), tetra-ri-butyl ammonium 
chloride (one equivalent) and a base (2.5 equivalents) in DMF 
at room temperature. The reaction, which was monitored by TLC 
analysis, was usually complete within 1-3 days (see Table 1). 
The cyclized product, 3-methylindole (^, skatole) was usually 
obtained in good yields. A typical reaction is represented 
below (eq. 19). Table 1 below lists the variety of conditions 
that were employed for the cyclization reactions. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11  
12 
13 
14 
15 
1. Pd-Catalyzed Cycllzations of Compounds 14a and 14b Leading to 2 in DMF 
Number of Number of Base 
days at room days at (2.5 
Substrate temperature 80®C 
Added salt Pd-catalyst Yield of 
eguiv.) (1 equiv.) ( 2  mole) 2 (%) 
NagCOg n-Bu^NCl Pd(OAc)g 97 
KgCO, n-Bu^NCl Pd(OAc)g 58 
NaHCOg n-Bu^NCl Pd(OAc)g 89 
LigCOj n-Bu^NCl Pd(OAc)g 18 
EtgN n-Bu^NCl Pd(OAc)g 84 
NagCOg - Pd(OAc)g 50 
NagCOj LiCl Pd(OAc)g 44 
- n-Bu^NCl PdCOAclg 5 
BtgN - Pd(OAc)g 22 
EtgNH jl-Bu^NCl Pd(OAc)g 0 
NaOAc jl-Bu^NCl Pd(OAc)g 34® 
NaOAc n-Bu^NCl Pd(OAc)g 93 
NagCOg n-Bu^NCl PdClg 52 
EtgN n-Bu^NCl PdClg 78 
NagCO^ n-Bu^NCl Pd(DBA)g 95 
14a 1 
14a 3 
14a 3 
14a 3 
14a 1 
14a 2 
14a 2 
14a 2 
14a 2 
14 a 1 
14a® 2 
14a 2 
14a 2 
14a 2 
14a 1 
VO 
-vj 
Table 1. Continued 
Entry Substrate 
Number of 
days at room 
temperature 
Number of 
days at 
80*C 
Base 
(2.5 
equiv.) 
Added salt 
(1 equiv.) 
Pd-catalyst 
(2 mole) 
Yield of 
2 (%) 
16 14b 1 2 NagCOg n-Bu^NCl Pd(0Ac)2 38 
17 14b ] 1 EtgN n-Bu^NCl Pd(OAc)2 0 
18 14b 2 1 NaOAc n-Bu^NCl Pd(OAc)2 6 
^Reaction run in DMSO. 
99 
rY\ H 2% Pd(0Ac)2 
n-Bu^NCl 
2.5 NagCOg 
DMF 
(19) 
\:H 3 
2 
RT, 1 day 
The results can be summarized as follows. The cyclization 
is affected by the type of base employed. The best results 
(in terms of shorter reaction time and higher product yields) 
were obtained with sodium carbonate, sodium acetate and 
triethylamine (entries 1, 5 and 12) as bases. Changing the 
palladium catalyst has guite an effect on both the yield of 
the product and the rate of the reaction. Pd(0Ac)2 and 
PdfDBAjg (DBA = dibenzylideneacetone) proved to be better than 
PdClg" As far as the substrate reactivity is concerned, the 
ortho-iodo compound 14a proved to be far superior to the 
ortho-bromo compound 14b. This was anticipated and there is 
26 literature precedent for this observation. The presence of 
the phase transfer reagent, ri-Bu^NCl, is essential as 
evidenced by entries 6, 7 and 9 (reactions done both in the 
absence of ri-Bu^NCl and in the presence of LiCl). In the 
absence of ^ -Bu^NCl the reaction shows little progress after 
one day and the yield of the product is low. Other phase 
transfer reagents such as tetra-n-butylammonium hydrogen 
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sulfate, tri-n-octylmethylammonium chloride or tetra-n-butyl-
ammonium bromide were not tried as it was reported by Jeffrey 
that tetra-ri-butylammonium chloride proved to be much more 
3? 
efficient. ' Other workers have used palladium(0) mediated 
oxidation of primary and secondary alcohols in the presence of 
the phase transfer reagent ji-Bu^NCl.^^ Of the many conditions 
listed above (see Table 1), it is obvious that sodium 
carbonate, sodium acetate or triethylamine should be employed 
as bases, PdfOAcjg as the catalyst, ii-Bu^NCl as the phase 
transfer reagent and N,N-dimethylformamide as the solvent in 
subsequent cyclization reactions. Cyclizations of substrates 
14a and 14b, mediated by catalytic amounts of PdfPPhg)^, 
leading to compound 2. have been reported by Hegedus et al. 
2 6 (see eg. 9). The product yields are 87% and 60%, 
respectively. 
The results of subsequent cyclization reactions performed 
on compounds and 15-21 are summarized in Table 2. The 
results reported in Table 2 can be explained as follows. 
Compound 2 undergoes cyclization smoothly to 1,3-dimethyl-
indole in good yields at room temperature, although the rate 
of the reaction is significantly slower than the reaction of 
compound 14a which took only one day to reach completion (see 
entry 1, Table 1). A substituent on the nitrogen thus slows 
down the cyclization. The analogous cyclization induced via 
an organocobalt intermediate gave the product in only 32% 
Table 2. Pd-Catalyzed Cyclization of Compounds 9^, and 15-21 in DM F in the Presence 
of Tetra-n-butylammonium Chloride 
Number of Number of 
Base days at room days at Isolated 
Substrate (2.5 equiv,) temperature 80°C Product yield (%) 
9 Na„CO- 3 — L il / 59 2 j 
10 
Et^N 2 - 10 81 
NaOAc 3 - 1£ 78 
15 EtgN 
CH. 
46 
23 
EtgN 
NagCOg 
NaOAc 
1 
3 
1 
23 
22 
23 
85 
65 
90 
Table 2. Continued 
Number of Number of 
Base days at room days at Isolated 
Substrate (2.5 equiv«) temperature 80°C Product yield (%) 
16 (starting 
material) 
76 
V 
24a 
29 
(not pure) 
or 
H 
I  
/ 
24b 
24a or 24b 22 
(not pure) 
17 (starting 
material) 
69 
16 NagCO^ 
16 NaOAc 
Et,N 
17 EtgN 
Table 2. Continued 
Number of Number of 
Base days at room days at Isolated 
Substrate (2.5 equiv.,) temperature 80*C Product yield (%) 
NaOAc - 1 many products -
NagCOg - 1 many products -
JL8® NSgCOg - 1 
1 
H 
26 
36 
NaOAc - 1 26 17 
EtgN - 1 26 65 
EtjN» - 1 26 12 
19 NagCOg 1 - none isolated 
®A11 reactions run in the presence of HCOgNa (one equivalent). 
^Two equivalents of HCOgNa were used. 
Table 2.  Continued 
Substrate 
Base 
(2.5 equiv.) 
Number of 
days at room 
temperature 
Number of 
days at 
80°C Product 
Isolated 
yield (%) 
NaOAc 1 - none isolated -
EtgN 1 - none isolated -
NagCOg - 1 none isolated -
NaOAc - 1 none isolated -
EtgN - 1 none isolated -
20 NagCOg 20 (starting 
material) 
55 
NaOAc 97 (84)' 
27 
27 54 
^Recrystallized yield. 
Table 2.  Continued 
Base 
Substrate (2.5 equiv.) 
Number of 
days at room 
temperature 
Number of 
days at 
80°C Product 
Isolated 
yield (%) 
21 EtgN 
NaOAc 
NagCOg 
1 
1 
CO^CH, 
2 8  
20 
1® 
28 
9 
7 
22 NagCOg 
NaOAc 
EtgN 
1 
1 
CHgCHg 
29 
12 
29 
43 
46 
73 
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from the corresponding chloro-substituted substrate in the 
In the case of the N-acetyl substrate 1^, the cyclization 
does not go to completion at room temperature. The yield of 
the desired product was only moderate (46%) at room 
temperature. Heating the reaction to 80®C, however, drives 
the reaction to completion. Perhaps, the lone pair of 
electrons on the oxygen of the carbonyl group is coordinating 
to the palladium and thus inhibiting addition to the double 
bond (Scheme 4). The 6-membered chelate shown in Scheme 4 can 
presence of a Ni(0) complex in 46% yield. 
Scheme 4 
L-
X X 
A 
Ac 
Pd(0) + 
CH 3 
23 
tie up the palladium and this explains the lack of reactivity 
of substrate at room temperature. The same compound 21 was 
obtained from ortho-thallated acetaniline in a fair yield 
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using Pd{II) and allyl chloride, although one eguivalent of 
20 the palladium(II) salt had to be used. 
Cyclization of substrate 16. should yield the corresponding 
tetrahydrocarbazole. However, a dihydrocarbazole was obtained 
instead, albeit in only a low yield and contaminated by an 
impurity. Surprisingly, further dehydrogenation to the 
aromatic carbazole did not occur (eg. 20). Proton NMR 
24b H 
spectral analysis indicated that there were two possible 
positions for the olefinic bond. A triplet at 6 2.88 
corresponding to the methylene group adjacent to the B ring 
provided clear evidence for one of the two assigned structures 
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(24a or 24b). The compound 24. (a or b) isolated from the 
sodium acetate run was relatively pure, in comparison with the 
one isolated from the Et^N run. Gas chromatographic (GC) 
analysis showed the presence of an impurity in minor amounts. 
However, the structure of the impurity could not be determined 
from GC/MS studies. The reason for the lack of reactivity in 
the presence of NagCO^ is not apparent. 
It was thought that a methyl substituent on the nitrogen 
might clean up the reaction. However, when compound 1% was 
subjected to the usual cyclization conditions (heated to 80°C 
for a day as the reaction fails to proceed at room 
temperature) many products were obtained in both the sodium 
acetate and the sodium carbonate runs. GC analysis revealed 
the presence of many products of which two of them were 
present in relatively larger amounts. Prom GC/MS studies the 
two major products appear to be compounds 25a and 25b or 
olefinic isomers of these compounds (eg. 21). The reaction 
other compounds 
was quite dirty and isolation of any single product by column 
chromatography proved too difficult. Thus, compound fared 
25a 25b 
+ (21) 
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better than compound 17 in yielding only one product. It 
should be noted that our cyclization oE compound 1_6 to the 
dihydrocarbazole product progressed much better than that 
O g 
reported by Hegedus et al. for the same compound. In his 
reaction with PdCPPh^)^ as the catalyst, only unreacted 
starting material (compound 1_6) was recovered. However, 
activated double bonds (conjugated to a carbonyl group) have 
been shown to assist in intramolecular addition reactions 
leading to carbazoles (see eg. 12).^^ 
The cyclization of compound ^  has some interesting 
features, since there are no g-hydrogens available for 
palladium hydride elimination to occur once the aryl palladium 
complex adds to the olefinic bond to form a 5-membered ring. 
However, if the aryl group is added to the terminal end of the 
double bond, the resulting a-palladium species has a 
B-hydrogen that would facilitate palladium hydride elimination 
(Scheme 5). As anticipated, no product was obtained upon 
submitting compound 1^ to cyclization both at room temperature 
and at 80°C. However, in the presence of one equivalent of 
sodium formate [which can reduce the a-all<ylpalladium( II) 
species to Pd(0)], the initially formed cyclic intermediate 
should split out Pd(0) as shown in Scheme 6. The a-palladium 
complex A, formed by initial addition of the aryl palladium 
species to the olefin, undergoes ligand exchange wherein the 
formate group displaces the anionic ligand in A. Expulsion of 
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Scheme 5 
1 PdX 
I 
!-HPdX 
H 
I 
X + Pd(0) 
H 
1 
X 
'N« 
Scheme 6 
HC02Na 
4> + NaX 
i \ 
PdOCOH 
-CO. 
I 
Pd(0) r •> < reductive 
elimination 
> 
PdH 
B 
I l l  
COg results in the formation of a a-alkylpalladium hydride 
species B which undergoes reductive elimination to give the 
final product 2^. Since Pd(0) is regenerated the reaction 
becomes catalytic in palladium. Reduction of vinyl and aryl 
halides by PdCPPh^)^ and sodium formate has been reported in 
the literature (eg. 22).^^ 
Our reaction proceeds best with Et^N as the base and worst 
with NaOAc as the base. Increasing the sodium formate concen­
tration to two equivalents, under our best (Et^N) conditions, 
decreased the yield to 12%. In all of the above reactions, an 
unidentifiable aliphatic product was also isolated. Since the 
•""H NMR spectrum of this compound had no aromatic protons, the 
formation of the reduced starting material was ruled out. 
However, the structure of this by-product could not be 
determined by spectral analysis. The cyclization reaction 
proceeds only at 80°C; at room temperature only unreacted 
starting materials could be isolated. While six-membered ring 
closure did not occur, such a ring closure has been observed 
in the cyclization of 2-bromo-N-(2-carboethoxyallyl)aniline to 
3-carboethoxyguinoline (eg. 23)." 
5% PdtPPhg)^ ( 2 2 )  
CgHgCH=CHBr 
(PhCHgjgN 
HC02Na 
110°C 
> CgHsCH=CH2 
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CO-.Et 
PdlPPhg)^ ^ (23) 
> 
CCuEt 
58% 
There are only a few methods reported for the synthesis of 
the indolinone (oxindole) nucleus even though this hetero­
cyclic system has been the focus of increasing attention 
b e c a u s e  o f  i t s  v a r i e d  p h y s i o l o g i c a l  p r o p e r t i e s . T h e  
synthesis of oxindole involving Pd(0) catalyzed hydrogénation 
40 
of an aryl nitrolactone is shown below (eq. 24). 
Pd/C 
«2 
(24) 
Organotransition metal approaches to the oxindole nucleus have 
30 28 been investigated by Mori and Ban and Terpko and Heck. 
28 Both organopalladiuit! [Pd(OAc) 2/^^^ catalyst] and organo-
nickel^® [Ni(PPh^)^] approaches yielded the oxindole product, 
but in only moderate yields (see eqs. 10 and 11). Our 
synthesis of oxindoles from the corresponding halide is 
basically a modification of the Ban and Heck methods. Thus, 
when compound 3^ was subjected to cyclization, no organic 
products could be isolated. This was the case with all three 
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bases at 80®C. At room temperature only starting materials 
were obtained with NagCO^ and NaOAc as bases. With Et^N, even 
at room temperature, no organic product was obtained. The 
reaction mixture which looks very messy may in fact contain a 
polymer of the starting material 19. 
However, phenyl-substituted oxindole 2% was formed very 
cleanly upon submitting the starting halide 22 to the usual 
cyclization conditions. The reaction proceeded very smoothly 
with NaOAc at 80°C in one day to form the oxindole 7n_ in 
nearly quantitative yield. The crude product which was very 
pure was recrystallized from a hexanes/chloroform mixture in 
84% yield. The same reaction in the presence of Et^N yielded 
the product in 54% recrystallized yield. The reaction does 
not proceed with sodium carbonate as the base. At room 
temperature, the reaction shows no progress with any of the 
28 three bases. Terpko and Heck obtained the same oxindole 21_ 
using 5% Pd(OAc)g/PPh^ in 58% yield, after heating the 
reaction at 110°C for 18 hours. Ban, who synthesized an 
analogous system, was able to achieve cyclization in 47% (his 
best) yield. 
Compound 21_ that was isolated could be a mixture of E and 
2 isomers. Differentiating the two isomers by NMR spectral 
studies was not possible. The existence of the two isomers 
was revealed only by NMR spectral studies (19 carbon 
28 
resonances were seen). Terpko and Heck reported the 
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formation of only one isomer. However, no analytical data on 
the compound were provided by him. 
Pd-catalyzed cyclization of compound 21^ to compound 2Z. 
proceeded in rather low yield (20%) with Et^N as the base at 
80*C for one day. As expected for disubstituted olefins the 
reaction does not occur at room temperature. Perhaps, steric 
hindrance is responsible for the slower reaction rates in 
these cases. In the presence of sodium carbonate and sodium 
acetate, the yields of the desired product were only 7% and 9% 
respectively. In addition to the desired product, a few other 
products were seen by TLC analysis. Separation of these 
compounds by column chromatography was not possible. Ban et 
al.^^ reported a yield of 43% of the same product 28^ using 
catalytic amounts of PdfOAcjg and PPhg in the presence of 
excess tetramethylethylenediamine (TMEDA) at 125°C. 
Substrate 22. cyclizes smoothly at 80°C to yield compound 
29 under the usual conditions. The best yield (73%) was 
obtained with Et^N as base. The yields of the cyclized 
product 22 were 46% and 43% with NaOAc and NajCO^ as bases, 
respectively. The reaction was complete within a day under 
EtgN and NaOAc conditions. With NagCOg, even after two days 
some of the starting material remained unreacted (33% 
isolated). At room temperature, cyclization was not observed 
even under the best (Et^N) condition. 
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The Pd(O)-catalyzed intramolecular addition of aryl 
halides to olefins leading to indole and oxindole derivatives, 
in the presence of a phase transfer reagent, is clearly 
superior to the existing methods. In some cases (compounds 
with monosubstituted olefins) our reaction proceeds very well 
at room temperature, whereas other workers cited above had to 
induce cyclization at very high temperatures. Compounds with 
disubstituted olefinic bonds had to be heated in order to 
effect cyclization. Still, in most cases the yields of the 
desired products were significantly higher when compared to 
those reported in the literature. Throughout the course of 
this work, only the cyclization of substrate 21. fell short of 
the yield reported in the literature. Overall, our 
modification of the existing methodology was very successful 
in the synthesis of indoles and their derivatives. Further 
studies in the synthesis of other heterocycles using our 
palladium-catalyzed methodology were carried out and will be 
discussed in the following section. 
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QUINOLINES 
A number of auinoline alkaloids have been isolated from 
rutaceous plants. Among them are edulitine , folimine 
(31) and folifidene (3_2). These alkaloids and many others 
bearing the guinoline ring system possess important biological 
properties and have been the target of synthesis for many 
years. Though many synthetic approaches have been 
described,the current discussion will concentrai 
organometallic approaches to the guinoline system. 
30 edulitine 21 R = OCH^ folinine 
32 R = OH folifidene 
In 1978, Cortese et al. extended the Pd-catalyzed vinylic 
substitution reaction to the synthesis of 2-guinolones. 
Reactions of 2-iodoaniline or its derivatives with dimethyl 
maleate would be expected to yield intermediate amino esters 
which would cyclize to guinolones. Indeed, this does occur in 
the three examples reported (eg. 25). Similarly, 4-phenyl-2-
guinoline was obtained in 66% yield by reacting o-iodoaniline 
with (^)-N-phenylcinnamamide (eg. 26). The stereochemistry is 
correct for direct cyclization, but as in the above case the 
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NH. 
^ cat. Pd(OAc). 
ÇO2CH3 
NH^ CC^CHg 
i-CHgOH (25) 
NH, 
H 
cat. Pd(OAc) 
CONHCJHc 
0 5 
EtgN 
100°C 
V 
CO„CH 
( 2 6 )  
use of (E)-N-phenylcinnamamide instead of the ^-isomer also 
gives the quinoline, but only in 15% yield. 
In an attempt to favor ring closure to six-membered ring 
quinoline products,- the palladium-promoted cyclization of 
a-substituted N-acryloyl-o-bromoanilines was studied (eq. 
27). 28 It was reasoned that the aryl group would prefer to 
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H 
lOO'C, EtgN 
•O 
( 2 7 )  
R 
add to the terminal methylene carbon rather than the tertiary 
carbon, as addition to the internal carbon would result in a 
a-alkylpalladium complex with no 6-hydrogen. 2-Quinolone 
derivatives were formed in this reaction but, surprisingly, 
their structures were not the expected ones. Two compounds 
were tested, one with an a-methyl group and the other with an 
a-phenyl group. The product in both cases was the 4-substi-
tuted 2-guinolones rather than the expected 3-substituted 
derivative (eg. 27). This rearrangement has been explained by 
the following mechanism (Scheme 7). The initial closure of 
the organopalladium intermediate leads to a five-membered ring 
product containing a 3-palladiomethyl group. In these 
complexes there is no B-hydrogen to be eliminated with 
palladium, as there is when the o-carbon is unsubstituted. 
Since the usual palladium hydride elimination is not possible, 
elimination of the aminocarbonyl group with the palladium 
appears to occur and this is followed by readdition of the 
aminocarbonylpalladium group to the resulting double bond in 
the opposite direction. The last adduct can now undergo 
palladium hydride elimination irreversibly to give the 
observed, rearranged 4-substituted 2-guinolone. 
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Scheme 7 
a.l Pd(OAc). PR. 
100 = 
,.NH 
'Pd i 
Br 
j>^ PdBr 
H 
V 
nf 
H 
-HPdsr _ n I r 
r 
R PdBr 
24 Hegedus et al. observed another unusual mode of 
cyclization when an amine-substituted allylbenzoquinone was 
subjected to stoichiometric palladium{II) treatment. They 
120 
observed exclusive formation of the quinoline product instead 
of the expected indole product (eq. 28). The reaction was 
0 
Pd(II) 
EtgN 
remarkably insensitive to the nature of the palladium 
catalyst. Upon repeating the same reaction, in the presence 
of benzoquinone (an oxidant) and in the absence of the 
palladium catalyst, the same quinoline product was observed. 
It was reasoned that this cyclization was an oxidative process 
effected by the benzoquinone, since benzoquinone alone was 
effective in the cyclization. Mori et al.^^ utilized a 
catalytic Ni(0) complex to induce intramolecular cyclization 
to dihydroquinoline derivatives (eq. 29). 
CH,MgBr 
£ > 
cat. NiCl2(PPh2)2 (29) 
Though this cyclization proceeds in high yield, subsequent 
rearrangement of the double bond and spontaneous aromatization 
to the desired quinoline has not been observed. Perhaps, a 
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secondary aniline would have been a better substrate for 
cyclization and ultimate dehydrogenation to quinolines. 
For our study, we chose the following substrates for 
cyclization. Compound 22 was made by methods reported in the 
a. 
33 34 35 
26 literature. This involves the treatment of ortho-iodo-
aniline with lithium diisopropylainide (LDA) and quenching with 
3-butenyl bromide (eq. 30). 
IL " VL NHg LDA 
'^S I / (30) 
THF 
-78°C+RT 
33 37% 
In order to prepare compound 21» first cis-5-(methane-
sulfonyloxy)pent-2-ene had to be made from the readily 
available pent-3-yn-l-ol. Thus, cis hydrogénation with 5% 
Pd/C [poisoned with Pb(0Ac)2] in the presence of one 
atmosphere of hydrogen yielded the cis-alkene in an almost 
quantitative yield. Mesylation of this alcohol was effected 
by treatment with triethylamine and methanesulfonyl chloride 
in dichloromethane (eq. 31). The overall yield for the two 
reactions was 
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*2' Pd/C CH^  CH2SO2CI 
CH^CECCH CH.OH i ^c=C & 
MeOH / \ ^ 
H H EtgN 
0°C (31) 
CH2CI2 
CH- ,CH-CH-OMs Jv / 2 2 
C=C 
36 
81%. ^-lodoaniline was treated with LDA and quenched with 
compound 36. to yield compound 34. in 43% yield. 
Compound ^  was prepared by the condensation of 
2-iodoaniline and vinylacetyl chloride (made by the treatment 
43 
of vinylacetic acid with oxalyl chloride in ether) (eq. 32). 
EtgN 
+ H2C=CHCH2C0C1 (32) 
THF 
0°C+RT 
35 
91 & (43% recrystallized) 
The best cyclization conditions used previously (Et^N, 
Na2C02 and NaOAc as bases) were then applied to these 
substrates. Table 3 shows the different conditions that were 
examined in attempting to induce cyclization to quinoline 
products. 
Thus, when compound 21 was subjected to the usual 
cyclization treatment [2% Pd(0Ac)2» n-Bu^NCl, base in DMF] the 
Table 3. Pd-Catalyzed Cyclization of Compounds 31-33 Leading to Quinolines 
Number of Number of 
Base days at room days at Isolated 
Substrate (2.5 equiv.) temperature BO^C Product yield (%) 
33 NagCOg 92-97 
NaOAc 
EtgN 
pyridine 
1 
1 
37 79 
33 (starting 75 
material) 
33 (starting ~100 
material) 
34 NagCOg 
EtgN 
NaOAc 
1 
1 
34 (starting 
material) 
34 (starting 
material) 
34 (starting 
material) 
NagCOg many products 
Et^N 
NagCOg 
NaOAC 
EtgN 
NagCOg 
NaOAC 
35 (starting 
material) 
35 (starting 
material) 
35 (starting 
material) 
unknown 
products 
unknown 
products 
unknown 
products 
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expected product 4-methyl quinoline (product of further 
dehydrogenation) was obtained in excellent yields with NagCOg 
and NaOAc as bases. In these reactions, Pd(0) metal was seen 
falling out of the reaction mixture after a few hours. 
However, under completely homogeneous conditions (pyridine and 
EtgN as bases), no reaction seemed to occur. In these cases 
only starting materials were isolated. Raising the reaction 
temperature was considered unnecessary. 
As anticipated, the disubstituted olefin 21 was less 
reactive when compared to compound 33_. The room temperature 
cyclization of compound 21 yielded only starting materials 
with all three bases. However, upon raising the reaction 
temperature to 80°C, the expected product 4-ethylquinoline 2Ê. 
was obtained in moderate yields using either triethylamine or 
sodium acetate as the base. The same reaction in the presence 
of NagCOg gave many products. 
Surprisingly, compound 35. âià not undergo cyclization to 
the desired 2-hydroxy-4-methylquinoline as expected. At room 
temperature, no reaction occurs, but upon heating to 80°C, 
many unidentifiable products were obtained. 
The yields of quinoline products obtained in our first two 
examples were much better than Ban's [both Ni(0) and 
Pd ( OAc ) 2/I'R3 catalysts were used]."^'^^ The reaction shows 
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much promise in that it could be used in the synthesis of more 
complex quinoline alkaloids and other natural products bearing 
this heterocyclic system. 
127 
ISOOUINOLINES 
Despite their simple structure, much interest in the 
isoquinoline alkaloids has developed over the years and 
several new naturally occurring compounds have been found. 
Plants belonging to the family Cactaceae are known to contain 
simple tetrahydroisoquinolines. Naturally occurring doryanine 
44 (39) and doryfomine (££) were isolated from sassafras tree. 
COÇ., TO:?-. 
39 doryanine 4 0 doryfomine 
A number of isoguinoline alkaloids possessing important 
biological properties exist in nature and many of them have 
45 been synthesized in the laboratory. 
Among the organometallic approaches to isoquinolines, the 
ones by Korte et al.^^ and Ban et al.^® are noteworthy. The 
Hegedus method was based upon %-allylnickel halides and 
n-olefin palladium complexes. Thus, 2-{2-propenyl)-N-methyl-
benzamide (4i_) was prepared from 2-bromo-N-methylbenzamide and 
n-allylnickel bromide (eg. 33). Compound £1^ was then 
subjected to intramolecular cyclization under stoichiometric 
Pd(II) conditions. The resultant cyclized isoguinolone was 
obtained in high yield. The major drawbacks to this approach 
are the use of air sensitive %-allylnickel complexes and 
stoichiometric amounts of a palladium(II) salt. 
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Vk_:. DMF H3O ONHMe 
1 PdCl2, 2CH2CN(33) 
: NaH 
+ Pd(0) 
Ban and co-workers'^^ obtained 4-benzylisoquinoline, along 
with the 4-benzylidene derivative, when the corresponding aryl 
halide was subjected to Pd-promoted cyclization (eg. 34). 
Ph 
CH„Ph 
cat. Pd(OAc)2-(PPh2)2 
TMEDA ^ 
125°C, 69 hrs 
CH2Ph 
(34) 
27% 8! 
CH2Ph 
The high temperature, the long reaction time and the low yield 
of the desired product (27%) make this procedure undesirable 
for synthetic purposes. The reason for the low reactivity of 
these halides may be due to the stable nature of the initially 
formed ortho-palladated dialkylaminobenzylpalladium complex 
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47 42« This may, to a certain extent, prevent intramolecular 
/ 
2 
ii 
addition to the olefinic bond. However, intermolecular 
additions of orthopalladated compounds have been 
reported.Recently, O'Sullivan and Parkins^^ reported 
the synthesis of isoindolinimines by the insertion of 
isocyanides into the metal-carbon bond of an ortho-palladated 
primary benzylamine complex (eg. 35). Cyclopalladated 
X-
Pd^ PhNC 
t t 2 > [Pd(CgH^CH2NH2){PhNC)Il 
(35) 
N- Ph 
«-
OH 
V 
NH- Ph 
complexes have also been (1) used to give insertion products 
with alkynes,^' (2) acylated in the presence of acetyl 
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52 
chloride to yield the ortho-substituted acylbenzylamine, and 
(3) carbonylated in the presence of CO to produce ortho-
53 54 palladated complexes. In 1983, Barr et al. reported a 
synthetic approach to the isoquinoline ring system via a 
cyclopalladated palladium complex (Scheme 8). Cyclopallada-
tion of compound £3^ occurs readily to yield complex 4_4 in the 
Scheme 8 
CO.Et 
43 
Li^PdCl^ 
N^ x^ CO^ Et 
Me 
Et 
\ 
b' 
I 
'N. 
CH. 
46 
/ 
ir 
o 
^^ O^ Et 
45 734 
presence of Pd(II). Upon treatment with methyl vinyl ketone, 
the expected substitution product was obtained in 73% 
yield. Compound £5 was then carried on to tetrahydroisoquino-
line £6 using known standard chemistry. As in the case of 
Hegedus ' method,the above scheme requires stoichiometric 
amounts of palladium. 
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Our method consists of essentially modifying the work done 
by Ban (see eq. 34). We decided to try to synthesize 
isoquinolines using catalytic amounts of PdfOAclg and 
tetra-n-butylaimnonium chloride as the phase transfer reagent. 
Hopefully, our methodology would provide better yields of the 
desired products. 
For our study we chose the following substrates 47-52 for 
cyclization. Compound £7 was prepared from 2-iodobenzyl-
alcohol by initial mesylation with methanesulfonyl chloride in 
NH 
'N 
48 
1 1  
50 
U NH 
52 
Ph 
the presence of Et,N, followed by treatment with excess 
allylamine. The overall yield for the two reactions was 91% 
(eq. 36). Compound £8_ was prepared by treating 2-iodobenzyl-
amine with LDA (1.5 equivalents) and quenching with 
allylbromide (two equivalents) (eq. 37). Compound ^  was 
prepared by the condensation of 2-iodobenzylamine with 
cinnamoyl chloride (eq. 38). Compounds ^ 2 ^"^<3 ^1_ were made 
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CHgSOgCl 
EtgN 
CH^Cl, 
0°C+RT 
OMs 
THF 
0°C+RT 
.NH, 
V 
47 
(36) 
'NH, 1.5 LDA 
2^^"^ Br 
-78°C»RT 
48 
66% 
(37) 
H ^COCl ^ ii (38) 
0°C+RT 84% recrystallized 
starting from 2-iodobenzoic acid. Upon treating the acid with 
excess oxalyl chloride in ether at 0°C, 2-iodobenzoyl chloride 
was obtained in almost quantitative yield. Allylamine was 
added to the acid chloride at 0°C in THF to yield amide 50, 
and cinnamyl amine along with excess (10 equivalents) 
triethylamine were added to the acid chloride to yield 
compound ^  (eq. 39). Compound ^  was obtained by treating 
the mesylate of 2-iodobenzylalcohol with cinnamyl amine (four 
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equivalents) and potassium carbonate (one equivalent) (eq. 
40) . 
CO^H (COCl)2 
—3» 
ether 
I 0°C, 15 hrs 
C^x^ C^OCl 
I O :^ • NK THF O'C 
63% 
recrystallized 
yield 
A 
if 
EtgN 
(39) 
o) NH 
51 
52% -
H recrystallized 
THF 
0°C 
yield 
OMs 
Ph 
^C=c 
H ^CH^NH^ 
K^CO, 
THF 
0°C+RT 
overnight 
(40) 
The results of the palladium-catalyzed cyclization of 
compounds 47-52 leading to isoquinolines are summarized in 
Table 4. 
Compound £7 undergoes smooth cyclization in the presence 
of 2% PdfOAcjg, n-Bu^NCl and DMF, to the desired 4-methyl-
isoquinoline 53 at 80°C with all three bases. However, the 
Table 4. Pd-Catalyzed Cyclizations of Compounds 47-52 
Reaction Reaction 
Pd catalyst Base temperature time Isolated 
Substrate (2%) (2.5 equiv.) (°C) (days) Product Yield (%) 
47 Pd(OAc) EtjN RT Starting 
material 
Pd(0Ac)2 NagCOg RT starting 
material 
Pd(OAc) NaOAc RT starting 
material 
Pd(0Ac)2 Nar,CO-, 2, J 80 UCJ T 
CH, 
53 
39 
Pd(0Ac)2 
Pd(0Ac)2 
Pd(PPh3)4' 
EtjN 
NaOAc 
Na2C0.j 
80 
80 
80 
1 
1 
1 
53 
starting 
material 
26 
23 
^Reaction run in the absence of phase transfer reagent. 
Table 4. Continued 
Substrate 
Pd catalyst 
(2%) 
Base 
(2.5 equiv.) 
Reaction 
temperature 
(°C) 
Reaction 
time 
(days) Product 
Isolated 
Yield (%) 
PdtPPhg)^ NagCOg 80 1 starting 
material 
-
lâ Pd(OAc)2 Et^N 80 1 starting 
material 
50 
Pd(0Ac)2 NagCO^ 80 1 many 
products 
-
Pd(0Ac)2 NaOAc 80 1 many 
products 
— 
49 Pd(0Ac)2 Na2C02 80 1 
r 
starting 
material 
' If r 
~70 
Pd(0Ac)2 NaOAc 80 
I; 
Ph 
54 
trace 
Table 4. Continued 
Reaction Reaction 
Pd catalyst Base temperature time Isolated 
Substrate (2%) (2.5 equiv.) (*C) (days) Product Yield (%) 
Pd(0Ac)2 EtgN 80 1 starting 
material 
43 
Pd(0Ac)2 NaOAc 100 1 M 21 
PdtPPhg)^ NaOAc 100 1 li 39 
PdCPPhj)^® NaOAc 100 1 starting 
material 
85 
Pd(0Ac)2 NaOAc 80 1 starting 
material 
95 
Pd(OAc)2 Et^N 80 1 starting 
material 
29 
Pd(0Ac)2 80 1 starting 
material 
50 
Pd(0Ac)2 NaOAc 100 1 many 
products 
— 
Pd(0Ac)2 100 2 starting 
material 
-
+ tar 
Table 4. Continued 
Pd catalyst Base 
Substrate (2%) (2.5 equiv.) 
Pd(0Ac)2 Et^N 
PdfPPhg)^ EtgN 
PdfPPhg)^* EtgN 
'^Ratio of 55/56 = 1. 
Reaction Reaction 
temperature time Isolated 
(°C) (days) Product Yield (%) 
Table 4. Continued 
Reaction Reaction 
Pd catalyst Base temperature time Isolated 
Substrate (2%) (2.5 equiv.) (°C) (days) Product Yield (%) 
56 
51 Pd(OAc) NagCOg 110 
Table 4. Continued 
Reaction Reaction 
Pd catalyst Base temperature time isolated 
Substrate (2%) (2.5 equiv.) (°C) (days) Product Yield (%) 
Pd(0Ac)2 NagCOg 110 6 2  
LI 
Ph 
57 
y 
Pd(OAc), EtgN 110 
52 Pd(OAc) Et^N 110 starting 9 
material 
Pd(OAc). 
Pd(OAc), 
NagCOg 
NaOAc 
110 
110 
140 
room temperature may be explained by the inability of the 
chelated ortho-palladation complex to undergo olefin 
insertion. Our best yield (39%) for this system is still much 
40 better, however, than the yield reported by Ban et al. (27%) 
for a similar system. The reaction in the presence of 2% 
PdfPPhg)^ yields only starting material, both in the presence 
and absence of the phase transfer reagent. 
The diallyl compound £8 fails to undergo cyclization to 
the desired isoquinoline either at room temperature or at 
80°C. At room temperature only starting materials were 
isolated. At 80°C, many products were formed with sodium 
carbonate and sodium acetate. With Et^N almost 50% of the 
starting material could be recovered. 
Compound 4^ does not cyclize at 80®C with NagCO^ or Et^N. 
However, with NaOAc trace amounts of the desired product ^  
were obtained. However, the reaction goes to completion in 
one day and the cyclic adduct ^  was obtained in 21% yield 
when the reaction was run with NaOAc as the base at 100°C. 
The reaction mixture turns tarry after prolonged heating (two 
days). In order to optimize the yield, the cyclization was 
carried out in the presence of 2% PdfPPhg)^ as the catalyst. 
This time the desired product was obtained in 39% yield; the 
other conditions remained the same. When the same reaction 
with Pd(PPh2)^ was carried out in the absence of the phase 
transfer reagent, none of the desired product could be 
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isolated. Thus, the phase transfer reagent is necessary to 
induce cyclization, but the role of the reagent is still open 
for discussion. The product ^  obtained is not a mixture of 
stereoisomers, but purely one isomer as indicated by NMR 
spectral studies. However, the stereochemistry could not be 
established from such limited data. 
Finally, compound ^  was subjected to the cyclization 
conditions. As suspected, only starting materials were 
obtained at 80°C. At 100*0, however, the desired product was 
obtained in 42% yield with Et^N as the base. The reaction 
gives many products with NaOAc, and with NSgCOg only starting 
material was recovered. As in the previous case, switching to 
the PdtPPhg)^ catalyst plus Et^N improved the yield to 58%. 
Surprisingly, the reaction seems to progress well even in the 
absence of the phase transfer reagent. In the absence of the 
phase transfer reagent, an almost 1:1 mixture of the 
completely aromatized product ^  and the initially formed 
cycloadduct 2Ê were obtained. The separation of these two 
products was not possible by column chromatography. The ratio 
1 13 
was determined by H NMR spectral analysis and the C NMR 
spectrum also revealed the presence of the two isomers. 
Compound cyclizes at 110°C under the usual conditions 
only in the presence of NajCO^ as base. However, the 
initially cyclized product 51_ did not undergo double bond 
migration to yield the desired isoquinoline product. In the 
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presence of NaOAc, compound ^1^ yields only the reduced 
product. With Et^N no organic product could be recovered. 
Compound ^  fails to undergo cyclization to the desired 
isocfuinoline under all three conditions (NaOAc, NagCOg, Et^N) 
at 110°C. With EtgN, only starting material (^9%) was 
recovered. In the presence of NagCO^ or NaOAc unidentifiable 
products were obtained. 
The presumed ability of our organopalladium approach to 
heterocycles to tolerate many functional groups during 
intramolecular cyclization should offer major advantages over 
the other methods presently available. Our methodology offers 
a solution to a lot of problems that were faced by chemists 
attempting similar cyclization reactions. The yields of the 
products obtained by our methodology are significantly higher 
than those reported in the literature for analogous systems. 
In addition, many of the cyclizations are achieved under 
milder reaction conditions. Also, some of the substrates, 
which were unreactive using other organopalladium methods, 
underwent cyclization to yield the desired products. 
Applications of this methodology to the synthesis of natural 
products, containing the heterocyclic systems studied, can be 
expected in the future. 
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OXYGEN HETEROCYCLES 
Intramolecular aryl palladium addition to olefins leading 
to oxygen heterocycles, such as benzopyrans, was also 
examined. As a model study, we decided to apply our previous 
best cyclization conditions to substrate ^ 8^. The synthesis of 
substrate was achieved in a straightforward manner (eg. 
41). Thus, o-iodophenol was treated with 4-bromobutene in 
acetone 1! 
1i-, 1 day 
^ 55% 
refluxing acetone, in the presence of K^COg, to yield compound 
58. The yield of compound ^  was 55%. 
Compound ^  was then subjected to the usual cyclization 
conditions, which involves treatment with 2% PdfOAcig, 
ri-Bu^MCl (one equivalent) and 2»5 equivalents of base (either 
NagCOg, NaOAc or Et^N) in DMF. Cyclization was observed at 
80°C only under NagCO^ conditions (eg. 42). However, the two 
o. 
2% Pd(OAc)_ 
n-Bu^NCl - I'j 
2.5 NagCOg 
DMF, 80'C 59 ^0 
isomers, compounds ^  and were obtained in a ratio of 
1.1:1. The combined yield of the two isomers was 58%. The 
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identity and the relative ratio of the two isomers were 
determined by NMR spectral analysis. Integration of the 
resonances due to one of the terminal vinylic protons and the 
only vinylic proton in isomer ^  in the NMR spectrum is the 
basis of our inference. Furthermore, GC/MS results added 
proof to our conclusion. The cyclization does not proceed at 
room temperature under the best (NagCO^) condition. 
Application of this reaction in the synthesis of other 
oxygenated heterocycles can be expected in the future. 
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EXPERIMENTAL SECTION 
Equipment 
Proton NMR spectra were recorded on a Nicolet NT-300 
spectrometer. NMR spectra were recorded on a Nicolet 
NT-300 (operating at 75 MHz for carbon nuclei) spectrometer. 
Infrared spectra were recorded on a Beckman-42050 
spectrophotometer. Mass spectral data were obtained on a 
Kratos high resolution mass spectrometer. Gas chromatographic 
analyses were performed using a Varian 3700 gas chroma tog raph 
equipped with an SE-30 capillary column or an OV-101 packed 
column. Melting points were measured on a Thomas-Hoover 
melting point apparatus and are uncorrected. 
Reagents 
All chemicals were used directly as obtained unless 
otherwise noted. N,N-DimethyIformamide (DMF) was distilled 
over calcium hydride under reduced pressure. Tetrahydrofuran 
(THF) was distilled over a sodium-benzophenone mixture. 
Tetra-n-butylammonium chloride (96%, Aldrich) was used 
directly as obtained and stored in a desiccator. Compounds 
14a-bf 16, and 1^ were prepared using a literature 
2 6 
procedure. Compounds 2» iZ' 22' 22' 21' and ^  were 
prepared basically by the same procedure.26 The following 
procedure for the preparation of compound 2 is representative 
of that used for the other compounds. 
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N-Allyl-2-iodoaniline (14a) (0.518 g, 2 mmol) was 
dissolved in 10 ml of dry THF in a 50 ml round bottom flask. 
The solution was flushed with nitrogen and cooled to -78°C 
(dry ice-acetone bath). LDA (2.1 mmol) (from 2.15 mmol of 
diisopropylamine and 2.15 mmol of n-butyllithium) in dry THF 
(3 ml) was slowly added, and the resulting mixture was allowed 
to warm to 0°C over 10 minutes. After the resulting solution 
was recooled to -78*0, methyl iodide (0.290 g, 2.2 mmol) was 
slowly added and the solution stirred for 10 minutes, allowed 
to warm to room temperature and stirred for two hours at that 
temperature. The reaction mixture was partitioned between 
ether and saturated sodium chloride solution and the ether 
layer separated. The ether extracts were dried over magnesium 
sulfate and concentrated. The crude oil was purified by 
medium pressure liquid chromatography using 2:1 hexanes/ethyl 
acetate as eluent. Compound £ was obtained in 85% (0.449 g) 
yield: 0.65 (2:1 hexanes/ethyl acetate); """H NMR (CDCl^) ô 
2.69 (3 H, s, NCHg), 3.55 ( 2 H, d, J = 6.3 Hz, allylic), 5.17 
(1 H- d, J = 10.2 Hz, terminal vinyl, cis to the internal 
vinylic hydrogen), 5.25 (1 H, d, J = 17.4 Hz, terminal vinyl, 
trans to the internal vinylic hydrogen), 5.95 (1 H, m, 
internal vinyl), 6.76 (1 H, m, aryl), 7.06 (1 H, d, J = 8.1 
Hz, aryl), 7.29 (1 H, m, aryl), 7.85 (1 H, d, J= 7.8 Hz, 
aryl); IR (neat) 3030 (C-H) cm ^; m/z calcd for C^gH^gNIf 
273.0014; found, 273.0015. 
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Compound ]/7 
Yield, 88%; 0.77 (30:1 hexanes/ethyl acetate); NMR 
(CDCI3) 6 1.26-2.03 (6 H, m, alkyl), 2.66 (3 H, s, NCH^), 3.91 
(1 H, m, NCH), 5.79 (2 H, m, vinyl), 6.74 (1 H, t, J = 7.5 Hz, 
aryl), 7.09 (1 H, d, J = 8.1 Hz, aryl), 7.28 (1 H, t, J = 7.5 
Hz, aryl), 7.85 (1 H, d, J = 7.8 Hz, aryl); IR (neat) 3050, 
3010 (C-H) cm ^;« m/z calcd for 313.03206; found, 
313.03275. 
Compound 22. 
yield, 98%; R^ 0.70 (10:1 hexanes/ethyl acetate); ^H NMR 
(CDCI3) 6 1.72 (3 H, m, CH^), 3.72 (2 H, t, J = 5.4 Hz, 
allylic), 4.21 (1 H, s, NH), 5.55-5.76 (2 H, vinyl, trans), 
6.43 (1 H, br t, J = 9 Hz, aryl), 6.56 (1 H, dd, = 8.4 Hz, 
Jg = 1.2 Hz, aryl), 7.19 (1 H, br t, J = 8.8 Hz, aryl), 7.65 
(1 H, dd, = 7.5 Hz, Jg = 1.5 Hz, aryl); IR (neat) 3395 
(NH), 3060 (C-H) CTP~^; m/z calcd for 273.00145; found 
273.0010. 
Compound 21 
Yield, 37%; Rg 0.80 (10:1 hexanes/ethyl acetate); ^H NMR 
(CDCI3) 6 2.43 (2 H, m, allylic), 3.21 (2 n, m, CHgN), 4.20 (1 
H, S, NH), 5.17 (1 H, d, J = 10.2 Hz, terminal vinyl, cis to 
the internal vinylic hydrogen), 5.22 (1 H, d, ^  = 17.2 Hz, 
terminal vinyl, trans to the internal vinylic hydrogen), 5.84 
(1 H, m, internal vinyl), 6.43 (1 H, t, J = 7.8 Hz, aryl). 
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6.54 (1 H, d, J = 7.8 Hz, aryl), 7.20 (1 H, m, aryl), 7.64 (1 
H, d, J = 7.8 Hz, aryl); IR (neat) 3480 (N-H) cm ^; m/z calcd 
for 273.00145; found, 273.00161. 
Compound 21 
Yield, 43%; 0.80 (10:1 hexanes/ethyl acetate); NMR 
(CDCI3) 6 1.71 (3 H, d, J = 7.2 Hz, CH^), 2.43-2.49 (2 H, m, 
allylic), 3.17-3.24 (2 H, m, CH^N), 4.22 (1 H, s, NH), 5.46 (1 
H, m, vinyl, cis), 5.69 (1 H, vinyl, cis), 6.45 (1 H, t, J = 
7.8 Hz, aryl), 6.59 (1 H, d, J = 7.5 Hz, aryl), 7.22 (1 H, t, 
J = 7.8 Hz, aryl), 7.66 (1 H, d, J = 7.8 Hz, aryl); IR (neat) 
3395 (NH), 1000 (C=C, cis) cm ^; m/z calcd for 
287.01710; found 287.01688. 
Compound ^  
Yield, 66%; 0.48 (15:1 hexanes/ethyl acetate); ^H NMR 
(CDCI3) S 3.16 (4 H, d, J = 6.9 Hz, allylic), 5.18 (2 H, d, J 
= 10.2 Hz, terminal vinyl, cis to the internal vinylic 
hydrogen), 5.25 (2 H, d, J = 17.4 Hz, terminal vinyl, trans to 
the internal vinylic hydrogen), 5.86-5.99 (2 H, m, internal 
vinyl), 6.96 (1 H, t, J = 7.8 Hz, aryl), 7.34 (1 H, t, J = 7.5 
Hz, aryl), 7.58 (1 H, d, J = 7.6 Hz, aryl), 7.84 (1 H, d, J = 
7.8 Hz, aryl); IR (neat) 3085 (C-H) cm ^; m/z calcd for 
^13^16^1 313.03275; found, 313.03224. 
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Preparation of compound 22 14a 
Compound 14a (0.518 g, 2 mmol) was treated with a large 
excess (1.5 ml) of acetic anhydride at room temperature. 
After two days, the reaction as indicated by TLC was complete. 
The crude mixture was washed with water and extracted with 
ether. The ether layer was concentrated and the residual 
acetic acid was removed under vacuum. The product which was a 
light yellow oil was used without further purification: 
yield, ~100% (0.600 g); NMR (CDCI3) 6 1.80 (3 H, s, CH^), 
3.60 (2 H, m, allylic), 5.06 (1 H, d, J = 18 Hz, terminal 
vinyl, trans to the internal vinylic hydrogen), 5.11 (1 H, d, 
J = 10.2 Hz, terminal vinyl, cis to the internal vinylic 
hydrogen), 5.89 (1 H, m, internal vinyl), 7.09 (1 H, t, J = 
7.5 Hz, aryl), 7.19 (1 H, d, J= 9.0 Hz, aryl), 7.40 (1 H, t, 
J = 7.8 Hz, aryl), 7.95 (1 H, d, J = 7.8 Hz, aryl); IR (neat) 
1740 (C=0) cm~^; m/z calcd for CgH^^NI (M^-COCH^), 257.9779; 
found 257.9780. 
Synthesis of compound 2^ from ortho-iodoacetanilide 
Sodium hydride (50%, 0.121 g, 2.52 mmol) was placed in a 
round bottom flask and washed with hexanes (three times). The 
residue was kept under vacuum to remove the remaining hexanes. 
The flask was flushed with nitrogen and cooled to 0°C. THF (9 
ml) was slowly added to the flask with constant stirring under 
nitrogen. The ortho-iodoacetanilide (0.471 g, 1.8 mmol) 
dissolved in 2 ml of THF was slowly added to the sodium 
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hydride-THF mixture. After the evolution of hydrogen had 
ceased, methyl 4-bromocrotonate (Aldrich) (0.390 g, 2.16 mmol) 
was added dropwise to the solution. The mixture was allowed 
to warm to room temperature and stirred at that temperature 
overnight. The reaction mixture was extracted with ether, 
washed with water and dried over anhydrous magnesium sulfate. 
Evaporation of the solvent yielded the crude product which was 
purified by column chromatography using 1:1 hexanes/ethyl 
acetate as eluent: 33% yield (0.215 g); 0.38 (1:1 
hexanes/ethyl acetate); NMR (CDCl^), 6 1.82 (3 H, s, 
COCRg), 3.68-3.84 (1 H, m, buried under OCH^ absorption, 
allylic), 3.73 (3 H, s, OCH^), 4.99 (1 H, dd, = 15.6 Hz, Jg 
= 3.6 Hz, allylic), 5.87 (1 H, d, J = 15.9 Hz, vinyl, trans), 
6.92-7.02 (1 H, m, vinyl, trans), 7.10 (1 H, t, J = 7.5 Hz, 
aryl), 7.21 (1 H, d, J = 7.8 Hz, aryl), 7.44 (1 H, br t, J = 
7.0 Hz, aryl), 7.95 (1 H, d, J = 7.8 Hz, aryl); IR (neat) 1720 
N 
I  _ i  
(C=0), 1665 (C=0) cm ; m/z calcd for C^^H^^NOgl 359.00185; 
found, 359.00156. 
Preparation of compounds 1^, 22, and ^  
The procedure for the synthesis of compound 22 is 
representative. To a mixture of ortho-iodoaniline (0.22 g, 1 
mmol) and cinnamoyl chloride (0.166 g, 1 mmol) was added 2 ml 
of THF. The solution was stirred at room temperature. 
Triethylamine (0.101 g, 1 mmol) was added dropwise to the 
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solution and the mixture was stirred for 16 hours. Water was 
then added to the solution and the product was extracted with 
three portions of ether. The combined ether extracts were 
washed with dilute aqueous hydrochloric acid and dried with 
anhydrous magnesium sulfate. Evaporation of the solvent 
yielded the crude amide (0.337 g, 94%). The crude product was 
dissolved in a minimum amount of boiling chloroform. The 
solution was allowed to cool to room temperature and hexanes 
were added dropwise to the solution until the first few 
crystals were seen. The solution was placed in a freezer 
overnight. The amide was obtained in 73% (0.254 g) recrystal-
lized yield; mp 154°C; NMR (CDCI3) g 6.59 (1 H, d, J = 15.6 
Hz, vinyl, trans), 6.85 (2 H, br t, J = 7.8 Hz, aryl), 
7.34-7.40 (4 H, m, aryl), 7.55-7.58 (2 H, m, aryl), 7.64 (1 H, 
s, NH), 7.75-7.80 (2 H, m, aryl and vinyl), 8.37 (1 H, d, J = 
8.1 Hz, aryl); IR (CHgClg) 3380 (NH), 1685 (C=0) cm"^ ; m/z 
calcd for CigH^glNO, 348.99590; found, 348.99637. 
Compound _1^ 
Yield, 80% (46% recrystallized); mp lOO^C; ^H NMR (CDCI3) 
6 5.58 (1 H, dd, = 10.2 Hz, Jg ~ 1.2 Hz, terminal vinyl, 
cis to the internal vinylic hydrogen), 6.30 (1 H, dd, = 
17.0 Hz, £2 = 1.2 Hz, terminal vinyl- trans to the internal 
vinylic hydrogen), 6.86 (1 H, ddd, ~ —2 ~ Hz, Jg = 1.4 
Hz, aryl), 7.59 (1 H, s, NH), 7.79 (1 H, dd, = 9 Hz, = 
1.4 Hz, aryl), 8.34 (1 H, d, J = 7.8 Hz, aryl); IR (CHgClg) 
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3380 (NH), 1690 (C=0) cm"^; m/z calcd for CgHgNOI 272.96507; 
found, 272.96471. 
Compound £7 
Yield, 99% (recrystallized yield, 84%); mp 176°C; NMR 
(CDCI3) 6 4.61 (2 H, d, J = 6.0 Hz, benzylic), 6.09 (1 H, s, 
NH), 6.42 (1 H, d, J = 15.6 Hz, vinyl), 6.99 (1 H, br t, J = 
7.8 Hz, aryl), 7.26-7.52 (7 H, m, aryl), 7.67 (1 H, d, J = 
15.6 Hz, vinyl), 7.84 (1 H, d, J = 7.8 Hz, aryl); IR (CHCI3) 
3440 (NH), 1665 (C=0), 1625 (C=C) cm m/z calcd for 
C16H14NOI 363.01202; found 363.01196. 
Preparation of compounds 3^ and ^  
The procedure for the synthesis of compound ^  is 
representative. Vinylacetic acid (0.225 g, 2.5 mmol) was 
added to dry ether (15 ml) kept at 0°C under nitrogen. To 
this mixture was slowly added oxalyl chloride (0.32 g, 2.5 
mmol) dissolved in 5 ml of ether and the mixture was stirred 
at 0°C overnight. This is to make sure that all of the acid 
has been converted to the corresponding acid chloride [in the 
preparation of the acid halide leading to compound ^  excess 
(15 equivalents) oxalyl chloride was used].^^ 2-Iodoaniline 
(0.440 g, 2 mmol) was dissolved in THF (10 ml) and cooled to 
0°C. Triethylamine (0.202 g, 2 mmol) was added slowly and the 
resulting mixture was stirred at O'C for ten minutes. The 
acid halide (in ether) was slowly added to the mixture by a 
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canula or a syringe under nitrogen (it should be noted that 
excess oxalyl chloride used in the other procedure was removed 
under vacuum before addition to the ortho-iodoaniline)» The 
resulting mixture was stirred at 0°C and allowed to warm to 
room temperature after two hours. The crude reaction mixture 
was poured into water and extracted with ether. The ether 
extract was dried over magnesium sulfate. After removal of 
ether under vacuum, the crude product was recrystallized from 
chloroform/hexanes mixture: crude yield, 51% (0.523 g); 
recrystallized yield, 43%; mp 86®C; NMR (CDClg) 6 1.63 (1 
H, s, NH), 3.24 (2 H, d, J = 7.2 Hz, allylic), 5.40 (1 H, d, J. 
= 10.0 Hz, terminal vinyl, cis to the internal olefinic 
hydrogen), 5.42 (1 H, d, J = 17.7 Hz, terminal vinyl, trans to 
the internal olefinic hydrogen), 6.02-6.13 (1 H, m, internal 
vinyl), 6.84 (1 H, t, J = 7.5 Hz, aryl), 7.34 (1 H, t, J = 7.8 
Hz, aryl), 7.77 (1 H, d, J = 7.8 Hz, aryl), 8.25 (1 H, d, J = 
8.1 Hz, aryl); IR (CHgClg) 3250 (NH), 1690 (C=0) cm"^; m/z 
calcd for C^ Q^H^ Q^NOI, 286.98072; found, 286.98089. 
Compound ^  
Yield, 98% (recrystallized yield, 65%); mp 105°C; ^H NMR 
(CDCI3) 6 4.10 (2 H, br t, J = 5.7 Hz, allylic), 5.22 (1 H, br 
d, J = 10.2 Hz, terminal vinyl, cis to the internal vinylic 
hydrogen), 5.33 (1 H, br d, J = 17.1 Hz, terminal vinyl, trans 
to the internal vinyl), 7.10 (1 H, br t, £ = 8.1 Hz, aryl), 
7.33-7.43 (2 H, m, aryl), 7.87 (1 H, d, J = 8.1 Hz, aryl); IR 
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(CH2CI2) 3435 (NH), 1660 (C=0) cm ^; m/z calcd for 
286.98072; found, 286.98054. 
Compound ^  
The same procedure was used except for a minor 
modification. Triethylamine was used in excess (10 
equivalents) in order to neutralize a minor amount of the 
contaminated cinnamyl hydrochloride present in the 
cinnamylamineYield, 52% (recrystallized); mp 136°C; 
NMR (CDCI3) 5 4.28 (2 H, br t, J = 6.9 Hz, CHg), 5.90 (1 H, br 
s, NH), 6.29-6.38 (1 H, m, vinyl, trans), 6.68 (1 H, d, J = 16 
Hz, vinyl, trans), 7.14 (1 H, t, J = 7.5 Hz, aryl), 7.25-7.47 
(7 H, m, aryl), 7.89 (1 H, d, J = 7.8 Hz, aryl); IR (CHCI3) 
3440 (NH), 1670 (C=0) cm~^; m/z calcd for C^gH^^NIO 363.01202; 
found 363.01229. 
Preparation of compound 42 from ortho-iodobenzyl alcohol 
To a mixture of ortho-iodobenzyl alcohol (0.468 g, 2 mmol) 
and triethylamine (0.202 g, 2 mmol) in dichloromethane (10 ml) 
at 0®C, was slowly added methanesulfonyl chloride (0.240 g, 
2.1 mmol). The resulting mixture was allowed to stir at 0°C 
for two hours. The crude mixture was washed with water and 
extracted with ether. After drying the ether extracts over 
anhydrous magnesium sulfate, the volatile solvents were 
removed on a rotary evaporator and the crude mesylate was used 
immediately without further purification. The crude mesylate 
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was dissolved in THF (10 ml) and cooled to 0°C. To this 
solution was added excess allylamine (1.71 g, 30 iranol) and the 
resultant mixture was allowed to warm to room temperature 
overnight. The crude reaction was poured into water and 
extracted with ether. The ether extracts were dried over 
anhydrous magnesium sulfate and the crude yellow oil was 
purified by column chromatography using 6:1 hexanes/ethyl 
acetate as eluent: yield, 91% (0.497 g); 0.14 (6:1 
hexanes/ethyl acetate); NMR (CDClg) 6 1.71 (1 H, s, NH), 
3.28 (2 H, d, J = 6.0 Hz, allylic), 3.81 (2 H, s, benzylic), 
5.13 (1 H, d, J = 10.2 Hz, terminal vinyl, cis to the internal 
vinylic hydrogen), 5.22 (1 H, d, J = 15.6 Hz, terminal vinyl 
trans to the internal vinylic hydrogen), 5.91-6.01 (1 H, m, 
internal vinyl), 6.95 (1 H, t, J = 7.5 Hz, aryl), 7.28-7.39 (2 
H, m, aryl), 7.82 (1 H, d, J = 7.8 Hz, aryl); IR (neat) 3300 
(NH) cm ^; m/z calcd for C^gH^gNI 273.00145; found 273.0063. 
Compound ^  
The synthesis of compound ^  was achieved as above except 
for minor modifications. Potassium carbonate (one equivalent) 
was used in order to neutralize any accompanying cinnamyl 
amine hydrochloride. Cinnamyl amine was used in a three fold 
excess; yield, 52%; Rg 0.18 (3:1 hexanes/ethyl acetate); ^H 
NMR (CDCI3) 5 1.88 (1 H, s, NH), 3.45 (2 H, d, J = 6 Hz, 
allylic), 3.87 (2 H, s, benzylic), 6.31-6.38 (1 H, m, vinyl, 
trans), 6.57 (1 H, d, J = 16 Hz, vinyl, trans), 6.96 (1 H, t, 
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J = 7.8 Hz, aryl), 7.19-7.41 (7 H, m, aryl), 7.83 (1 H, d, J = 
7.8 Hz, aryl); IR (neat) 3310 (NH), 3060 (C-H) cm ^; m/z calcd 
for C^gH^gNI 349.03275; found 349.03244. 
Preparation of compounds 2,  20., 23-24, 26-29, 37-38, 53-57 
The procedure for the synthesis of compound is 
representative. Palladium acetate (1.12 mg, 0.005 mmol); 
sodium carbonate, triethylamine or sodium acetate (0.625 
mmol); and tetra-n-butylammonium chloride (69.5 mg, 0.25 mmol) 
were placed in a culture tube equipped with a stirrer and a 
screw cap. A solution of compound 17a (65 mg, 0.25 mmol) in 
DMF (0.4 ml) was slowly added with stirring under a stream of 
nitrogen via a 1 ml syringe. The syringe was further rinsed 
with 0.10 ml of DMF and added slowly to the reaction mixture 
(in cases where the starting halides are solids, their 
dissolution in DMF prior to addition is not necessary). The 
tube was sealed after the addition and the reaction, which was 
usually over in a day with NagCOg was monitored by TLC. After 
a day, the reaction mixture was diluted with ether and washed 
with brine and water. The ether extracts were dried over 
anhydrous magnesium sulfate and concentrated under vacuum to 
yield the crude product. The crude product was dissolved in a 
minimum amount of ethyl acetate or chloroform and filtered 
through a short (three inches) silica gel column using 15:1 
hexanes/ethyl acetate as eluent. Compound 2 was obtained in 
97% yield (sodium carbonate was the base used): mp 94°C 
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(lit.56 mp 95-96°C); NMR (CDCI3) 5 2.35 (3 H, s, CH^), 
6.88-7.69 (6 H, m, aryl and N-H). Compared with NMR 
spectrum in ref. 57. 
5 8 Compound 10^ 
Yield, 81%; 0.33 (30:1 hexanes/ethyl acetate); NMR 
(CDCI3) 6 2.32 (3 H, s, CHg), 3.72 (3 H, s, NCH^), 6.81 (1 H, 
Sf aryl)/ 7.10 (1 H, t, — 7.6 Hz, aryl), 7.26 (2 H, m, 
aryl), 7.56 (1 H, d, J = 9.3 Hz, aryl); ^ ^C NMR (CDCI3) 6 
137.20, 126.56, 121.51, 118.99, 118.60, 110.28, 109.02 (all 
aryl), 32.50 (NCH^), 9.55 (CH^); IR (neat) 3100 (C-H) cm"^; 
m/z calcd for C^qH^^N (M+-H) 144.0812; found 114.0811. 
Compound 21 
Yield, 90%; Rg 0.60 (2:1 hexanes/ethyl acetate); NMR 
(CDCI3) 6 2.23 (3 H, s, CH3), 2.62 (3 H, s, COCH3), 7.09 (1 H, 
s, aryl), 7.32 (3 H, m, aryl), 7.57 (1 H, d, J = 9.2 Hz, 
aryl); ^^C NMR (CDCI3) 6 168.07 (C=0), 135.97, 131.51, 125.14, 
123.36, 122.22, 118.79, 118.34 and 116.57 (all aryl), 23.88 
and 9.61 (aliphatic); IR (neat) 1710 (C=0) cm m/z calcd for 
CiiHiiNO 173.0842; found 173.0844. 
Compound 21 
Yield, 29% (slightly impure by GC); Rg 0.55 (30:1 hexanes/ 
ethyl acetate); ^H NMR (CDCI3) 6 2.49 (2 H, m, allylic), 2.86 
(2 H, br t, J = 15 Hz, CHgCN), 5.93-5.99 (1 H, m, vinyl), 6.39 
(1 H, br d, J - 11.7 Hz, vinyl), 7.11 (2 H, m, aryl), 7.49 (1 
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H, m, aryl), 7.76 (1 H, s, NH); IR (CHCl^) 3490 (NH) cm"^; m/z 
calcd for C^gHgN 167.0735; found 167.0735. 
59 Compound 2É 
Yield, 65%; 0.49 (30:1 hexanes/ethyl acetate); NMR 
(CDCI3) 6 1.29 (6 H, s, CHg's), 3.29 (2 H, s, CHg), 3.65 (1 H, 
br s, NH), 6.62 (1 H, d, J = 7.5 Hz, aryl), 6.72 (1 H, t, J = 
7.5 Hz, aryl), 6.98-7.03 (2 H, m, aryl); NMR (CDCl^) 6 
127.31, 122.00, 118.80, 109.64 (all aryl), 61.79 (CHgN), 41.86 
and 27.69 (aliphatic); IR (neat) 3480 (NH) cm m/z 
calcd for C^gH^^N 147.1048; found 147.1048. Anal, calcd for 
C10H13N: C, 82.38; H, 8.88. Found C, 82.45; H, 8.37. 
Compound 
Yield, 97% (recrystallized yield, 84%); mp 176-178*'C 
(lit.28 mp 175-176°C); ^H NMR (CDCI3) 6 6.84-6.94 (2 H, m, 
aryl), 7.19-7.25 (2 H, m, aryl), 7.41-7.50 (3 H, m, aryl), 
7.62-7.69 (3 H, m, aryl), 7.85 (1 H, s, vinyl), 9.06 (1 H, s, 
NH); note: integration from 6 7.19-7.69 could not be 
determined accurately. It is possible that there are two 
isomers; ^^C NMR (CDCI3) 6 170.58 (C=0), 141.99, 140.08, 
137.40, 135.00, 131.97, 130.44, 129.89, 129.58, 129.32, 
128.95, 128.64, 128.25, 127.91, 123.05, 121.77, 119.28, 
110.36, 109.75; IR (CHCI3) Ô 3460 (NH), 1705 (C=0) cm~^; m/z 
calcd for C^gH^^NO 221.08407; found 221.0836. 
159 
Compound 2^ 
Yield, 20%; 0.35 (2:1 hexanes/ethyl acetate); NMR 
(CDCI3) 5 2.63 (3 H, Sr COCH3), 3.74 (3 H, s, OCH3), 3.74 (2 
H, s, CHg, buried under the singlet due to OCHg), 7.26-7.40 (2 
H, m, aryl), 7.45 (1 H, s, aryl), 7.52 (1 H, d, J = 6.9 Hz, 
aryl), 8.43 (1 H, d, J = 8.1 Hz, aryl); IR (neat) 1735 (C=0), 
1680 (C=0) cm ^; m/z calcd for C^^H^gNOg 231.0875; found 
231.0877. 
Compound 29_ 
Yield, 73%; R^ 0.24 (10:1 hexanes/ethyl acetate); ^H NMR 
(CDClg) 6 1.33 (3 H, t, J = 7.5 Hz, CH^), 2.78 (2 H, q, J = 
7.5 Hz, CHg), 6.93 (1 H, s, aryl), 7.08-7.20 (2 H, m, aryl), 
7.31 (1 H, d, J = 7.8 Hz, aryl), 7.61 (1 H, d, J = 7.8 Hz, 
aryl), 7.84 (1 H, br s, NH); ^^C NMR (CDCI3) 6 136.49, 127.48, 
121.90, 120.45, 119.09, 118.96, 118.86, 111.07 (all aryl), 
18.40 and 14.52 (aliphatic); IR (neat) 3420 (NH), 3050 (C-H) 
cm ^; m/z calcd for Cj^gH^^^^N 145.08915; found 145.08919. 
Compound 37^^ 
Yield, 97%; Rg 0.30 (5:1 hexanes/ethyl acetate); ^H NMR 
(CDCI3) S 2.65 (3 H, s, CHg), 7.15 (1 H, br d, J = 7.0 Hz, 
aryl), 7.40-8.22 (4 H, m, aryl), 8.75 (1 H, d, J = 7.2 Hz, 
aryl); compared with NMR spectrum in réf. 57. 
:6o 
Compound 38^^ 
Yield, 55%; 0.29 (5:1 hexanes/ethyl acetate); NMR 
(CDClg) 6 1.40 (3 H, t, J = 7.5 Hz, CH^), 3.12 (2 H, q, J = 
7.5 Hz, CHg), 7.25 (1 H, d, J = 4.2 Hz, aryl), 7.56 (1 H, dt, 
= 7.2 Hz, J^2 ~ 1"4 Hz, aryl), 7.70 (1 H, br t, J = 7.5 Hz, 
aryl), 8.04 (1 H, d, J = 8.7 Hz, aryl), 8.12 (1 H, d, J = 8.4 
Hz, aryl), 8.82 (1 H, d, J = 4.5 Hz, aryl); NMR (CDCI3) 
150.31, 149.89, 148.21, 130.21, 128.92, 127.47, 126.24, 
123.39, 119.77 (all aryl), 25.03 and 14.03 (aliphatic); IR 
(neat) 3060, 3030 (C-H) cm ^; m/z calcd for 157.08915; 
found 157.08890. 
Compound ^ 
Yield, 39%; R^ 0.30 (2:1 hexanes/ethyl acetate); ^H NMR 
(CDCI3) 6 2.62 (3 H, s, CHg), 7.60 (1 H, t, J = 8.1 Hz, aryl), 
7.74 (1 H, t, J = 7.8 Hz, aryl), 7.93-7.98 (2 H, iti, aryl), 
8.37 (1 H, 8, aryl), 9.11 (1 H, s, aryl); ^^C NMR (CDCI3) 6 
151.15, 143.00, 135.40, 130.13, 128.27, 128.09, 127.21, 
126.88, 123.14 (all aryl), 15.78 (aliphatic); IR (neat) 3080 
(C-H) cm ^ ; m/z calcd for C j^ qH^N 143.07353; found 143.07327. 
Anal, calcd for C^ qH^N; C, 83.94; H, 6.29. Found C, 83.72; 
H, 6.40. 
Compound ^ 
Yield, 39%; R^ 0.18 (1:1 hexanes/ethyl acetate); mp 
195-198°C; ^H NMR (CDCI3) 6 4.47 (2 H, d, J = 4.5 Hz, 
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benzylic) ,  6.79 (1 H, br s, NH), 7.07-7.38 (7 H, m, vinyl and 
aryl), 7.64 (1 H, d, J = 1.5 Hz, aryl), 7.71 (2 H, d, J = 7.2 
Hz, aryl); NMR (CDCI3) 6 167.28 (C=0), 136.68, 136.04, 
135.53, 132.09, 130.22, 129.31, 128.41, 127.91, 127.89, 
127.47, 125.14, 124.01 (aryl and vinyl), 45.00 (benzylic); IR 
(CHCI3) 3405 (NH), 1670 (C=0) cm"^ ; m/z calcd for C^gH^^^NO 
235.09972; found 235.09915. Anal, calcd for C, 
81.74; H 5.57. Found C, 81.93; H, 5.34. 
Compound _5^ 
Yield, 58%; Rg 0.18 (1:1 hexanes/ethyl acetate); mp 
157-159°C (lit.GO mp 173*C); NMR (CDCI3) 6 2.25 (3 H, s, 
CH3), 6.99 (1 H, s, aryl), 7.46-7.70 (3 H, m, aryl), 8.42 (1 
H, d, J = 7.2 Hz, aryl), 11.64 (1 H, s, OH); NMR (CDCI3) 6 
164.06, 138.50, 132.48, 127.82, 126.53, 126.13, 125.43, 
123.33, 112.46 (all aryl), 15.30 (aliphatic); IR (CHjClj) 3050 
(OH), 1650 (C=N) cm ^; m/z calcd for C^^HgNO 159.06842; found 
159.06816. Anal, calcd for C^gHgNO: C, 75.50; H, 5.66. 
Found C, 75.30; H, 5.97. 
Compound 5^ 
Yield, 33%; Rg 0.17 (1:1 hexanes/ethyl acetate); ^H NMR 
(CDCI3) 5 4.05 (2 H, s, allylic), 6.92 (1 H, s, vinyl), 
7.20-7.62 (8 H, m, aryl), 8.45 (1 H, d, J = 8.1 Hz, aryl), 
11.61 (1 H, s, NH); ^^C NMR (CDClg) 5 139.12, 137.75, 132.52, 
128.67, 127.95, 126.86, 126.59, 126.53, 126.43, 126.35, 123.52 
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and 115.53 (aryl and vinyl), 35.60 (allylic); IR (CHClg) 3400 
(N-H), 1650 (C=0) cm"^; m/z calcd for 235.09972; 
found 235.09990. Anal, calcd for C, 81.74; H, 
5.57. Found C, 80.41; H, 5.58. 
Preparation of compound ^ from ortho-iodophenol 
In a round bottom flask was added potassium carbonate 
(0.304 g, 2.2 mmol), ortho-iodophenol (0.440 g, 2 mmol), 
acetone (5 ml) and 4-bromo-l-butene. The mixture was refluxed 
for 24 hours under nitrogen. After cooling, the reaction 
mixture was poured into water (30 ml) and extracted with 
ether. The ether extract was dried and concentrated under 
vacuum. The residue was purified by column chromatography 
using 10:1 hexanes/ethyl acetate as eluent. Compound ^ was 
obtained in 55% (0.302 g) isolated yield: 0.65 (10:1 
hexanes/ethyl acetate); NMR (CDClg) S 2.82 (2 H, q, J= 6.6 
Hz., allylic), 4.25 (2 H, t, J = 6.6 Hz. OCH-), 5.32 (1 H, d. J 
= 10.2 Hz, terminal vinyl, cis to the internal vinylic 
hydrogen), 5.40 (1 H, br d, J = 17.1 Hz, vinyl, trans to the 
internal vinylic hydrogen), 6.10-6.22 (1 H, m, internal 
vinyl), 6.89 (1 H, dt, = 7.5 Hz, = 1.2 Hz, aryl), 6.99 
(1 H, dd, = 7.2 Hz, £2 = 1.5 Hz), 7.44-7.50 (1 H, m, aryl), 
7.96 (1 H, dd, = 7.8 Hz, = 1,5 Hz, aryl); IR (neat) 3060 
(C-H) cm~^; m/z calcd for C^gH^^OI 273.98547; found 273.98505. 
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Compounds ^ and 60_ 
The two isomers, compounds ^ and 60^ (ratio 1.1:1) were 
obtained by the palladium-catalyzed cyclization (see the 
procedure outlined for the synthesis of compound of 
compound yield, 68%; 0.65 (10:1 hexanes/ethyl 
acetate); NMR (CDCI3) S 2.03 (3 H, s, CH^), 2.69 (2 H, t, J 
= 5.4 Hz, allylic hydrogens of isomer 59_), 4.25 (2 H, t, J = 
5.7 Hz, OCHg of isomer 59), 4.75 (2 H, m, OCHg of isomer 60), 
4.90 (1 H, br s, vinyl hydrogen of isomer ^) , 5.52 (1 H, br 
s, vinyl hydrogen of isomer 59.) » 5.58 (1 H, m, vinyl hydrogen 
of isomer ^) , 6.79-7.20 (7 H, m, aryl hydrogens of both 
isomers), 7.59 (1 H, d, J= 7.5 Hz, aryl hydrogen of one of 
the two isomers); IR (neat) 3050 (C-H) cm ^; GC/MS (isomer 59) 
146 (M+), 131; (isomer 60^) 146 (m"""), 131 (M^-CHg, base peak). 
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ORGANGPALLADIUM APPROACHES TO CARBOCYCLES 
Our success in the synthesis of heterocyclic aromatic 
compounds via palladium(O) catalysts prompted us to extend 
this methodology toward the synthesis of aromatic carbocycles, 
particularly naphthalenes and naphthols. There are many 
natural products such as tetracyclic antibiotics that contain 
the naphthalene ring system. 
As a model study, we decided to apply our best cyclization 
conditions to the following systems (compounds 1.-^) • The 
synthesis of compounds 2 and 2_ was achieved in a straight­
forward manner starting from ortho-iodobenzyl alcohol (Scheme 
1). Thus, ortho-iodobenzyl alcohol was converted to ortho-
iodobenzaldehyde by treatment with 1.5 equivalents of 
pyridinium chlorochromate (PCC) in CHgClg at room temperature 
for two hours.^ Upon treatment of the Grignard reagent 
derived from 4-bromo-l-butene with o-iodobenzaldehyde in ether 
at 0°C, compound 1_ was obtained in a 67% isolated yield. 
OH 
2 3 
4 
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Scheme I  
^CH OH 
I J., 
PCC 
CH^Cl, 
RT 
2 hrs 
> 1 
ether 
0°C 67% 
Jigl 
PCC 
6 hrs 
2 <- — 
95% 
Compound 2 was prepared by the PCC oxidation of compound 
Compound 2 was prepared by the treatment of o-iodobenzaldehyde 
with the Grignard reagent derived from 5-iodo-cis-2-pentene 
(prepared from 3-pentyl-l-ol by standard methods as outlined 
in equation 1). The. yield of compound 2 was fairly low (15%). 
Hg/Pd CH^ • MsCl 
CH_C = CCH_CH-OH > ^C=C > 3 2 2 " /  \  
H H EtgN 
-100% 0°C 
^"3 CH2CO2OMS CH CH^CH^I (1) 
^C=c 2 Nal -^C=c"^ - -
H CH^COCH^ Tj/ \,T 
95% reflux gg% 
171 
The following methods were employed in the synthesis of 
compound 4, but all of them were unsuccessful (eqs. 2-4). 
.CHgOR 
R = Ms, £-tosyl 
:-îgBr 
^ many products (2) 
0°C, ether 
CHgBr 
•MgBr 
^ mostly bibenzyl 
0°C, ether products 
(3) 
cat. Li-,CuCl 
Thus, when either the methanesulfonate or tosylate of 
o-iodobenzyl alcohol were treated with the Grignard reagent 
made from. 4-bromo-l-butenemany products were obtained (eg. 
2). However, when o-iodobenzyl bromide was treated with the 
sarne Grignard reagent, mostly bibenzyl products were obtained. 
When the organocuprate derived from the Grignard reagent of 
4-bromo-l-butene was treated with o-iodobenzyl bromide, a 
bibenzyl coupled product was obtained exclusively. At this 
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stage, further attempts were not carried out in the synthesis 
of compound 
The three best bases (EtgN, NaOAc and NagCO^ as bases) 
reported in the previous section were chosen for the 
Pd-catalyzed cyclization of compounds The attempted 
conditions and the products obtained from compounds l^-^ are 
listed in Table 1. 
When compound 1^ was subjected to the usual cyclization at 
room temperature (in the presence of PdfOAcïg and one 
equivalent of n-Bu^NCl in DMF), compound 2 was isolated as the 
only product with all three bases. Surprisingly, not even a 
trace of the expected 6-membered ring alcohol or 1-methylnaph-
thalene (the product of cyclization and subsequent 
dehydration), could be seen (eg. 5). This observation can be 
OH 
2% Pd(OAc), —\ 
^ [ J ) 
n-Bu^NCl (5) 
DMF CHCHG 
base 
RT i 
following scheme (Scheme 1). Thus, initial isomerization of 
the olefinic bond in substrate 1^, followed by cyclization 
would yield compound The reaction proceeds in excellent 
yields as indicated in Table 1. The olefinic stereochemistry 
in the product could not be determined by NMR spectral 
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Table 1. Pd-Catalyzed Cyclization of Compounds 1^-3^ 
Base Reaction Reaction 
(2.5 temp. time Isolated 
Substrate equiv.) (°C) (days) Product yield (%) 
EtgN RT 
OH 
CH. 
69 
Na^CO, 
NaOAc 
RT 
RT 
1 
1 
5 
5 
41 
84 
Na^COg RT 
I) 
64 
CH^CH, 
34 
EtgN RT 6 
7 
50 
45 
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Table 1. Continued 
Base Reaction Reaction 
(2. 5 temp. time Isolated 
Substrate eauiv.) (°C) (days) Product yield (%) 
NaOAc RT 2 6_ 
2 
47 
10 
starting 40 
material 
0*2:03 80 1 no products -
NaOAc 80 1 no products -
EtgN 80 1 £ 
OH 
49 
3 NagCOg 80 2 
w 
CH2CH 
91 
•3 
NaOAc 80 2 8 83 
EtgN 80 2 _8 78 
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C *^ wi a 1 T T 
Î cyclization 
i 
1 
5 
13 1 
studies, although both C NMR and H NMR spectra revealed the 
presence of only one isomer. 
Compound 2 undergoes cyclization smoothly to yield a 
mixture of two products, compounds §_ (the prcx3uct of initial 
cyclization) and % (the product formed from double bond 
migration after initial cyclization) at room temperature. 
The desired compound 7_ could not be obtained exclusively. 
Separation of the two isomers was accomplished by flash column 
chromatography. The combined yield of the two compounds (£ 
and 2) was quite good with Et^N and NagCO^ serving as bases. 
At 80°C, Et_N yielded compound 6_ exclusively in a 49% yield; 
the other two bases yielded polymeric products. 
Compound 2 undergoes cyclization at 80°C with all three 
bases. Even here, cyclization of the starting material seemed 
to occur after initial internal migration of the double bond. 
The product £ (one stereoisomer) was isolated in very high 
yields with all three bases. 
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The cyclization reactions reported above yielded an 
aromatic product with only one substrate. As these reactions 
did not look promising in the synthesis of polycyclic 
aromatics, further studies were not carried out. 
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EXPERIMENTAL SECTION 
Equipment 
Proton NMR spectra were recorded on a Nicolet NT-300 
spectrometer. NMR spectra were recorded on a Nicolet 
NT-300 (operating at 75 MHz for carbon nuclei) spectrometer. 
Infrared spectra were recorded on a Perkin-Elmer spectrometer. 
Mass spectral data were obtained on an MS-50 high resolution 
mass spectrometer. 
Reagents 
All chemicals were used directly as obtained commercially 
unless otherwise noted. N,N-Dimethylformamide (DMF) was 
distilled over calcium hydride. Methylene chloride was 
distilled over phosphorous pentoxide. Ortho-iodobenzaldehyde 
was prepared from commercially available ortho-iodobenzy1 
alcohol (Aldrich) by the method reported by Corey.^ Ether was 
distilled over CaHg. 
Preparation of compounds 2 and 2 
The procedure for the synthesis of compound 1. is 
representative of that used to prepare compound 2» To a dry 
round bottom flask equipped with a side arm and a reflux 
condenser was added powdered magnesium metal (100 mg, 4.1 
mmol) and 4 ml of '".eshly distilled ether. To this mixture, 
under nitrogen, was added 4-bromobutene (0.27 g, 2 mmol) and 
ethylene dibromide (0.316 g, 2 mmol) dissolved in 1 ml of 
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ether. After the exothermic reaction had subsided, the flask 
was cooled to 0°C in an ice bath, and ortho-iodobenzaldehyde 
(0.402 g, 1.73 mitiol) slowly added. The mixture was stirred at 
0°C for 3 0 minutes and allowed to warm to room temperature for 
an additional 30 minutes. The mixture was then quenched with 
brine and extracted with ether. The ether extracts were dried 
over anhydrous magnesium sulfate and concentrated to give the 
crude product. The product was purified by column 
chromatography over silica gel using 5:1 hexanes/ethyl acetate 
as eluent. Compound 3^ was obtained in 67% yield (0.334 g) ; 
Rg 0.40, 5:1 hexanes/ethyl acetate; NMR (CDCl^) 5 1.68-1.87 
(3 H, m, CHg and OH), 2.22-2.29 (2 H, m, allylic), 4.89-4.93 
(1 H, m, benzylic), 4.99-5.12 (2 H, m, terminal vinyl), 
5.85-5.95 (1 H, m, internal vinyl), 6.96 (1 H, t, J = 7.8 Hz, 
aryl), 7.37 (1 H, t, J = 7.5 Hz, aryl), 7.51 (1 H, d, J = 7.8 
Hz, aryl), 7.80 (1 H, d, J= 7.5 Hz, aryl); IR (neat) 3380 
(OH), 3060 (C-H) cm m/z, calcd for 288.0013; found 
288.00133. 
Compound 3_ 
Fifteen percent yield; R^ 0.40, 5:1 hexanes/ethyl acetate? 
^H NMR (CDCI3) S 1.60-1.84 (5 H, in, aliphatic), 2.10 (1 H, br 
s, OH), 2. 23-2.30 (2 H, m, allylic), 4.88-5.00 (1 H, m, 
benzylic), 5.48-5.54 (2 H, m, vinyl, cis), 6.96 (1 H, t, J = 
7.5 Hz, aryl) , 7.36 (1 H, t, J = 7.5 Hz, aryl) ,  7.52 (1 H, d, 
J = 7.8 Hz, aryl), 7.80 (1 H, d, J = 7.8 Hz, aryl); IR (neat) 
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3380 (OH), 3050 (C-H) cm"^; m/z calcd for 302.0014; 
found 302.00142. 
Compound 2 
Pyridinium chlorochromate (0.353 g, 1.64 iranol) was 
suspended in methylene chloride (3 ml) and the benzylic 
alcohol 1^ (0.313 g, 1.09 mmol) dissolved in 1 ml of 
dichlororaethane was rapidly added at room temperature. The 
reaction, which was monitored by thin layer chromatography, 
was complete after six hours. The black reaction mixture was 
diluted with ether, the solvent was decanted, and the black 
solid was washed twice with ether. The product (compound 
was isolated simply by filtration of the organic extracts 
through Florisil and evaporation of the solvent at reduced 
pressure. Yield 95% (0.294 g); NMR (CDCl^) 6 2.49 (2 H, br 
q, J = 6.6 Hz, allylic), 3.00 (2 H, t, J = 7.2 Hz, COCHg), 
5.00-5.12 (2 H. m, terminal vinyl), 5.83-5.93 (1 H, m, 
internal vinyl), 7.09-7.15 (1 H, m, aryl), 7.34-7.41 (2 H, m, 
aryl), 7.91 (1 H, d, J = 8.1 Hz, aryl); IR (neat) 3070 (C-H), 
1695 (C=0) cm m/z calcd for 285.98547; found 
285.98559. 
Pd-catalyzed cyclization of compounds leading to 
carbocycles 5 ,  2 and £  
The cyclizations were carried out as outlined in the 
experimental section of the preceding section. 
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Compound ^ 
Eighty-four percent yield, 0.18, 5:1 hexanes/ethyl 
acetate. NMR (CDCl^) 5 1.96 (1 H, s, OH), 2.09 (3 H, br q, 
J = 1.6 Hz, CH^), 2.53 (2 H, m, allylic) , 4.71 (1 H, m, 
benzylic), 5.78 (1 H, m, vinyl), 7.24-7.39 (4 H, m, aryl); 
NMR (CDCI3) Ô 137. 14, 134. 39, 131.81, 128. 28, 127.43, 126.66, 
123.42, 121.94 (aryl and vinyl), 68.19 (benzylic), 32.70 
(allylic) and 19.14 (CH^); IR (neat) 3370 (OH), 3050 (C-H) 
cm m/z calcd for C^^H^gO 160.0888; found, 160.0884. Anal, 
calcd for % C, 81.56; H, 7.47. Pound C, 81.23; H, 
7.45. 
Compound 
Sixty-four percent yield; 0.45, 6:1 hexanes/ethyl 
acetate; ^H NMR (CDCl^) 5 2.74-2.79 (2 H, m, allylic), 
2.83-2.88 (2 H, m, COCHg), 5.27 (1 H, br s, vinyl), 5.58 (1 H, 
br s. vinyl), 7.39 (1 H, t, J = 8.1 Hz, aryl), 7.54 (1 H, dt, 
= 6.6 Hz, £2 ~ 1» 6 Hz, aryl ), 7.65 (1 H, d, J = 7.2 Hz, 
aryl), 8.15 (1 H, dd, = 7.8 Hz, = 1.5 Hz, aryl); ^^C NMR 
(CDCl^) 6 197.61, 127. 17, 124. 74, 111. 55 (aryl and vinyl), 
39.37 and 32.54 (aliphatic); IR (neat) 3080 (C-H), 1680 (C=0) 
cm ^; m/z calcd for C^^H^gO 158.07317; found 158.07298. Anal, 
calcd for C^^H^QO: C, 83.58; H, 6.38. Found C, 83.42; H, 
6. 42. 
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Compound 7_ 
Forty-nine percent yield; 0.32, 6:1 hexanes/ethyl 
acetate; NMR (CDCl^) 6 2.60 (3 H, s, CH^), 5.35 (1 H, br s, 
OH), 6.70 (1 H, d, J = 7.5 Hz, aryl), 7.12 (1 H, d, J = 7.5 
Hz, aryl), 7.47-7.56 (2 H, m, aryl), 7.93 (1 H, d, J = 7.8 Hz, 
aryl) ,  8.21 (1 H, d, J = 7.8 Hz, aryl); NMR (CDCI3) S 
149.96, 133.59, 126.63, 126.24, 126.12, 124. 91, 124.66, 
124.23, 122.09, 108.18 (all aryl), 18.82 (CH^); IR (neat) 3580 
(OH), 3040 (C-H) cm m/z calcd for 158.07317; found 
158.07321. Anal, calcd for C^^H^gO: %C, 83. 58; %H, 6.38. 
Found %C, 83.74; %H, 6.42. 
Compound 8_ 
Ninety-one percent yield; R^ 0.22, 6:1 hexanes/ethyl 
acetate; ^H NMR (CDCI3) 6 1.18 (3 H, t, J = 7.2 Hz, CH^), 1.82 
(1 H, br s, OH), 2.47-2.57 (4 H, m, allylic), 4.67-4.74 (1 H, 
m, benzylic),- 5,79 (1 H. m, vinyl). 7.23-7.42 (4 H, m, aryl); 
^^C NMR (CDCI3) 6 133.74, 133.64, 128.24, 127.34, 126.75, 
123.16, 119.89 (aryl and vinyl), 68.29 (benzylic), 32.67 and 
25.23 (allylic), 13.00 (CH^); IR (neat) 3340 (OH), 3060 (C-H) 
cm~^; m/z calcd for 174.10447; found 174.10485. Anal, 
calcd for C^gHiaO: %C, 82.80; %H, 8.04. Found %C, 82.76; %H, 
7.89. 
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SUMMARY 
Organopalladium approaches to interphenylene prostaglandin 
analogsheterocycles and carbocycles have been examined. 
Three new prostaglandin analogs, a number of heterocycles and 
carbocycles have been synthesized. In particular, our 
synthetic approaches to heterocyclic compounds have been very 
successful and this methodology can be explored further in the 
synthesis of complex, biologically active natural products. 
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